RO134616A0 - Innovative formula with carnosine and pyrroloquinoline quinone for oral administration with the role of neutralizing free radicals in the body - food supplement - Google Patents
Innovative formula with carnosine and pyrroloquinoline quinone for oral administration with the role of neutralizing free radicals in the body - food supplement Download PDFInfo
- Publication number
- RO134616A0 RO134616A0 ROA202000173A RO202000173A RO134616A0 RO 134616 A0 RO134616 A0 RO 134616A0 RO A202000173 A ROA202000173 A RO A202000173A RO 202000173 A RO202000173 A RO 202000173A RO 134616 A0 RO134616 A0 RO 134616A0
- Authority
- RO
- Romania
- Prior art keywords
- parts
- vitamin
- extract
- carnosine
- antioxidant
- Prior art date
Links
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 title claims abstract description 48
- 108010087806 Carnosine Proteins 0.000 title claims abstract description 16
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 title claims abstract description 16
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 230000003472 neutralizing effect Effects 0.000 title abstract description 4
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 title description 11
- 229940044199 carnosine Drugs 0.000 title description 11
- 235000015872 dietary supplement Nutrition 0.000 title description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 51
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000203 mixture Substances 0.000 claims abstract description 28
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims abstract description 27
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 23
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 21
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 21
- 239000011718 vitamin C Substances 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 20
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 17
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 17
- 239000011709 vitamin E Substances 0.000 claims abstract description 17
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910052802 copper Inorganic materials 0.000 claims abstract description 16
- 239000010949 copper Substances 0.000 claims abstract description 16
- 229960002477 riboflavin Drugs 0.000 claims abstract description 16
- 229940046009 vitamin E Drugs 0.000 claims abstract description 16
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000002775 capsule Substances 0.000 claims abstract description 15
- 235000019136 lipoic acid Nutrition 0.000 claims abstract description 14
- 229960002663 thioctic acid Drugs 0.000 claims abstract description 14
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 11
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 11
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 11
- 239000001168 astaxanthin Substances 0.000 claims abstract description 11
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 11
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 11
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 11
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 11
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 10
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 10
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 9
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 8
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract description 8
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 7
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 7
- 241001236212 Pinus pinaster Species 0.000 claims abstract description 6
- 235000005105 Pinus pinaster Nutrition 0.000 claims abstract description 6
- 239000011787 zinc oxide Substances 0.000 claims abstract description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 4
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 4
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 4
- 238000009472 formulation Methods 0.000 claims abstract description 3
- 229940098324 green tea leaf extract Drugs 0.000 claims abstract description 3
- 239000008513 turmeric extract Substances 0.000 claims abstract description 3
- 229940052016 turmeric extract Drugs 0.000 claims abstract description 3
- 235000020240 turmeric extract Nutrition 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims abstract 3
- 235000006708 antioxidants Nutrition 0.000 claims description 45
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 22
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 22
- 235000021283 resveratrol Nutrition 0.000 claims description 22
- 229940016667 resveratrol Drugs 0.000 claims description 22
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 20
- 235000013824 polyphenols Nutrition 0.000 claims description 19
- 244000163122 Curcuma domestica Species 0.000 claims description 17
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 16
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 16
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 16
- 229940074393 chlorogenic acid Drugs 0.000 claims description 16
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 16
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 16
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 16
- 244000269722 Thea sinensis Species 0.000 claims description 15
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 15
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 229920002770 condensed tannin Polymers 0.000 claims description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 235000018192 pine bark supplement Nutrition 0.000 claims description 8
- 229940106796 pycnogenol Drugs 0.000 claims description 8
- 235000006468 Thea sinensis Nutrition 0.000 claims description 6
- 235000019192 riboflavin Nutrition 0.000 claims description 5
- 239000002151 riboflavin Substances 0.000 claims description 5
- 229940075614 colloidal silicon dioxide Drugs 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- 229930003799 tocopherol Natural products 0.000 claims description 4
- 239000011732 tocopherol Substances 0.000 claims description 4
- SOECUQMRSRVZQQ-UHFFFAOYSA-N ubiquinone-1 Chemical compound COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O SOECUQMRSRVZQQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000005487 catechin Nutrition 0.000 claims description 2
- 229950001002 cianidanol Drugs 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- 235000014375 Curcuma Nutrition 0.000 claims 1
- VVYPIVJZLVJPGU-UHFFFAOYSA-L copper;2-aminoacetate Chemical compound [Cu+2].NCC([O-])=O.NCC([O-])=O VVYPIVJZLVJPGU-UHFFFAOYSA-L 0.000 claims 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 abstract description 3
- 229940106587 pine bark extract Drugs 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 description 35
- 230000003078 antioxidant effect Effects 0.000 description 33
- 239000011701 zinc Substances 0.000 description 21
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 20
- 229910052725 zinc Inorganic materials 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- 235000016804 zinc Nutrition 0.000 description 19
- 150000003254 radicals Chemical class 0.000 description 18
- 239000000523 sample Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 235000003373 curcuma longa Nutrition 0.000 description 16
- 230000032683 aging Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 15
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 14
- 235000003392 Curcuma domestica Nutrition 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 238000000605 extraction Methods 0.000 description 11
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 11
- 235000013976 turmeric Nutrition 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 210000000987 immune system Anatomy 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 8
- 235000009569 green tea Nutrition 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 230000036542 oxidative stress Effects 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 208000024827 Alzheimer disease Diseases 0.000 description 7
- 208000024172 Cardiovascular disease Diseases 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000001590 oxidative effect Effects 0.000 description 7
- 229960005489 paracetamol Drugs 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- 238000011088 calibration curve Methods 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 235000012754 curcumin Nutrition 0.000 description 6
- 239000004148 curcumin Substances 0.000 description 6
- 229940109262 curcumin Drugs 0.000 description 6
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 208000015122 neurodegenerative disease Diseases 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000035558 fertility Effects 0.000 description 5
- 229960003180 glutathione Drugs 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 229940118019 malondialdehyde Drugs 0.000 description 5
- 230000004770 neurodegeneration Effects 0.000 description 5
- 210000002569 neuron Anatomy 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 235000017550 sodium carbonate Nutrition 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 4
- JVJFIQYAHPMBBX-UHFFFAOYSA-N HNE Natural products CCCCCC(O)C=CC=O JVJFIQYAHPMBBX-UHFFFAOYSA-N 0.000 description 4
- 206010019851 Hepatotoxicity Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 208000020832 chronic kidney disease Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 231100000304 hepatotoxicity Toxicity 0.000 description 4
- 230000007686 hepatotoxicity Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000003859 lipid peroxidation Effects 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 229960004203 carnitine Drugs 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229960002885 histidine Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 230000002438 mitochondrial effect Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 2
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 2
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 239000001692 EU approved anti-caking agent Substances 0.000 description 2
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 241000168517 Haematococcus lacustris Species 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- YDGMGEXADBMOMJ-LURJTMIESA-N N(g)-dimethylarginine Chemical compound CN(C)C(\N)=N\CCC[C@H](N)C(O)=O YDGMGEXADBMOMJ-LURJTMIESA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 102100036407 Thioredoxin Human genes 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 102100033220 Xanthine oxidase Human genes 0.000 description 2
- 108010093894 Xanthine oxidase Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229910052785 arsenic Inorganic materials 0.000 description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 2
- 229940079293 ascorbic acid 40 mg Drugs 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 208000037998 chronic venous disease Diseases 0.000 description 2
- 210000000078 claw Anatomy 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 229940031192 coenzyme Q10 10 mg Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000005228 liver tissue Anatomy 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 235000009048 phenolic acids Nutrition 0.000 description 2
- 235000020741 pine bark extract Nutrition 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002633 protecting effect Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000006176 redox buffer Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 108060008226 thioredoxin Proteins 0.000 description 2
- 125000002640 tocopherol group Chemical class 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- GIANIJCPTPUNBA-QMMMGPOBSA-N (2s)-3-(4-hydroxyphenyl)-2-nitramidopropanoic acid Chemical compound [O-][N+](=O)N[C@H](C(=O)O)CC1=CC=C(O)C=C1 GIANIJCPTPUNBA-QMMMGPOBSA-N 0.000 description 1
- JVJFIQYAHPMBBX-FNORWQNLSA-N (E)-4-hydroxynon-2-enal Chemical compound CCCCCC(O)\C=C\C=O JVJFIQYAHPMBBX-FNORWQNLSA-N 0.000 description 1
- YXEAENVLZOODMT-VOTSOKGWSA-N (e)-non-3-enal Chemical compound CCCCC\C=C\CC=O YXEAENVLZOODMT-VOTSOKGWSA-N 0.000 description 1
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- HJTAZXHBEBIQQX-UHFFFAOYSA-N 1,5-bis(chloromethyl)naphthalene Chemical compound C1=CC=C2C(CCl)=CC=CC2=C1CCl HJTAZXHBEBIQQX-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- VXYSFSCCSQAYJV-UHFFFAOYSA-N 2-methylpropanedial Chemical compound O=CC(C)C=O VXYSFSCCSQAYJV-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- ZGCHLOWZNKRZSN-NTSWFWBYSA-N 3-deoxyglucosone Chemical compound OC[C@@H](O)[C@@H](O)CC(=O)C=O ZGCHLOWZNKRZSN-NTSWFWBYSA-N 0.000 description 1
- UHPMJDGOAZMIID-UHFFFAOYSA-N 3-deoxyglucosone Natural products OCC1OC(O)C(=O)CC1O UHPMJDGOAZMIID-UHFFFAOYSA-N 0.000 description 1
- ZIUYHTQZEPDUCZ-UHFFFAOYSA-N 7h-pyrrolo[2,3-h]quinoline Chemical compound C1=CN=C2C(C=CN3)=C3C=CC2=C1 ZIUYHTQZEPDUCZ-UHFFFAOYSA-N 0.000 description 1
- FPGSEBKFEJEOSA-UMMCILCDSA-N 8-Hydroxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O FPGSEBKFEJEOSA-UMMCILCDSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 1
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 241000723382 Corylus Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 108010001202 Cytochrome P-450 CYP2E1 Proteins 0.000 description 1
- 102100024889 Cytochrome P450 2E1 Human genes 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010053070 Glutathione Disulfide Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 1
- 125000000415 L-cysteinyl group Chemical group O=C([*])[C@@](N([H])[H])([H])C([H])([H])S[H] 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000003896 Myeloperoxidases Human genes 0.000 description 1
- 108090000235 Myeloperoxidases Proteins 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- MZUSCVCCMHDHDF-UHFFFAOYSA-N P(=O)(=O)[W] Chemical class P(=O)(=O)[W] MZUSCVCCMHDHDF-UHFFFAOYSA-N 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 101710093328 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 1
- 102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 101100008569 Rattus norvegicus Cst4 gene Proteins 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000013200 Stress disease Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 102000049398 Vasodilator-stimulated phosphoproteins Human genes 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 231100000439 acute liver injury Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- GOLCXWYRSKYTSP-UHFFFAOYSA-N arsenic trioxide Inorganic materials O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- YDGMGEXADBMOMJ-UHFFFAOYSA-N asymmetrical dimethylarginine Natural products CN(C)C(N)=NCCCC(N)C(O)=O YDGMGEXADBMOMJ-UHFFFAOYSA-N 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 239000002012 ayurvedic medicine Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000021024 carbohydrate-rich diet Nutrition 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000013216 cat model Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000006567 cellular energy metabolism Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid group Chemical class C(C=CC1=CC=CC=C1)(=O)O WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000020988 fatty fish Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000008437 mitochondrial biogenesis Effects 0.000 description 1
- 230000004065 mitochondrial dysfunction Effects 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 230000017095 negative regulation of cell growth Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000003955 neuronal function Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000004005 nitrosamines Chemical class 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020986 nuts and seeds Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- -1 organosulfate compound Chemical class 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000009057 passive transport Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000010204 pine bark Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N trans-stilbene Chemical class C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 108010054220 vasodilator-stimulated phosphoprotein Proteins 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 125000001020 α-tocopherol group Chemical group 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
DescriereDescription
Invenția de față se referă la un produs - AGE MANAGEMENT AOX - bazai pe o combinație originală de ingrediente active având ca principii active noi: L-carnosina și pirolochinoHnă quinonă, și care asociază în formulă unică o serie de compuși cunoscuți pentru efectul antioxidant respectiv coenzima Q10, biocurcumină (turmeric), resveratrol (Polygonum Cuspidatum), acid alfa lipoic, vitamina C (acid ascorbic), extract de pin, carnitină, astaxantin, polifenoli din ceai verde, vitamina E, Zn sub formă de oxid de zinc, cupru sub formă de bisgiicinat de cupru, vitamina B2 (riboflavină), destinat administrării la adulți, cu rol antioxidant.The present invention relates to a product - AGE MANAGEMENT AOX - based on an original combination of active ingredients having as new active principles: L-carnosine and pyrroloquinone, which combines in a single formula a series of compounds known for their antioxidant effect and coenzyme. Q10, biocurcumin (turmeric), resveratrol (Polygonum Cuspidatum), alpha lipoic acid, vitamin C (ascorbic acid), pine extract, carnitine, astaxanthin, green tea polyphenols, vitamin E, Zn as zinc oxide, copper under form of copper bisgiicinate, vitamin B 2 (riboflavin), intended for administration to adults, with antioxidant role.
Exista pe piață numeroase produse pe bază de curcumina, CoQ10, resveratrol, vitamine, picnogenol, ceai verde, acid alfa lipoic, in premiera am realizat o formulă pe bază de carnosina si Pirolochinolina Quinonă pentru administrare orală, în prevenția modificărilor biochimice legate de acumularea radicalilor liberi în organism.There are many products on the market based on curcumin, CoQ10, resveratrol, vitamins, pycnogenol, green tea, alpha lipoic acid, for the first time we made a formula based on carnosine and Pyrroloquinoline Quinone for oral administration, in preventing biochemical changes related to radical accumulation free in the body.
AGE MANAGEMENT AOX se referă la o compoziție pentru capsule sau comprimate caracterizată prin aceea că aceasta cuprinde 0,88 părți (m/m) excipienți de formulare (stearat de magneziu și dioxid de siliciu coloidal) - 2,19% m/m și principii active originale LCarnosină 4 părți - 9,93% m/m, Pirolochinolina Quinonă (PQQ) 0,13 părți - 0,31% m/m, L-Carnitina 11 părți (m/m) - 27,30% m/m, vitamina C/acid ascorbic 40 părți - 9,93% m/m, extract din frunze de Ceai verde (Camellia sinensis) - standardizat la 50% polifenoli 7,50 părți - 18,61% m/m din care 3,75 părți polifenoli (epigalocatechingaiat) 9,3% m/m, extract de turmeric (Curcuma longa) 4 părți - 9,93% m/m, acid alfa lipoic 3,28 părți - 8,13% m/m, astaxantină 1,5 părți - 3,72% m/m, extract din rădăcină de Polygonum Cuspidatum 1,25 părți - 3,10% m/m cu 50% resveratrol (0,625 părți - 1,6% m/m), extract din scoarță de Pinmaritim (Pinus pinaster) 1,25 părți - 3,10% m/m standardizat în 99% picnogenol (1,24 părți - 3,07%), coenzima Q10/ubiquinonă 1 (o) parte - 2,48% m/m, dry - vitamina E 50% CWS/S (forma solidă, depusă pe substrat de amidon) 0,3 părți 0,74% m/m - cu 0,15 părți vitamina E/tocoferol - 0,37% m/m, oxid de zinc 0,16 părți - 0,39% m/m (Zinc 12,5% VNR*), bisgiicinat de cupru 0,04 părți - 0,11% m/m (Cupru 12,50% VNR*), vitamina B2/riboflavină 0,02 părți - 0,04% m/m (12,50% VNR*); *VNR - procent din Valorile Nutriționale de Referință cf. Regulamentului 1169/2011.AGE MANAGEMENT AOX refers to a composition for capsules or tablets characterized in that it comprises 0.88 parts (m / m) excipients of the formulation (magnesium stearate and colloidal silicon dioxide) - 2.19% m / m and principles original active LCarnosine 4 parts - 9.93% m / m, Pyrroloquinoline Quinone (PQQ) 0.13 parts - 0.31% m / m, L-Carnitine 11 parts (m / m) - 27.30% m / m , vitamin C / ascorbic acid 40 parts - 9.93% m / m, green tea leaf extract (Camellia sinensis) - standardized to 50% polyphenols 7.50 parts - 18.61% m / m of which 3.75 parts polyphenols (epigallocatechinage) 9.3% m / m, turmeric extract (Curcuma longa) 4 parts - 9.93% m / m, alpha lipoic acid 3.28 parts - 8.13% m / m, astaxanthin 1, 5 parts - 3.72% m / m, Polygonum Cuspidatum root extract 1.25 parts - 3.10% m / m with 50% resveratrol (0.625 parts - 1.6% m / m), bark extract Pinmaritim (Pinus pinaster) 1.25 parts - 3.10% m / m standardized in 99% pycnogenol (1.24 parts - 3.07%), coenzyme Q10 / ubiquinone 1 (o) part - 2.48% m / m, dry - vitamin E 50% CWS / S (solid form, deposited on starch substrate) 0.3 parts 0.74% m / m - with 0.15 parts vitamin E / tocopherol - 0.37% m / m, zinc oxide 0.16 parts - 0.39% m / m (Zinc 12.5% VNR *), copper bisgiicinate 0.04 parts - 0.11% m / m (Copper 12.50% VNR *), vitamin B2 / riboflavin 0.02 parts - 0.04% m / m (12.50% VNR *); * VNR - percentage of the Nutritional Reference Values according to Regulation 1169/2011.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Acțiunea produsului AGE MANAGEMENT AOX este determinată în principal de combinația de principii active din compoziția sa.The action of the AGE MANAGEMENT AOX product is mainly determined by the combination of active principles in its composition.
Asocierea celor 15 principii bioactive dm plante (turmeric, resveratrol, picnogenol, astaxantina) vitamine (vitamina B2, C, E) și minerale (Cu, Zn), aminoacizi din care două molecule în premieră - carnosina și PQQ - determină un efect sinergie antioxidant, antiîmbătrânire și de neutralizare a radicalilor liberi produși în mod continuu în organismul uman, reglează nivelul colesterolului, protejează sistemul nervos, protejează vederea, întărește sistemul imunitar, cu roi în prevenția bolilor degenerative si a bolilor cardiovasculare.The combination of the 15 bioactive principles in plants (turmeric, resveratrol, pycnogenol, astaxanthin), vitamins (vitamin B2, C, E) and minerals (Cu, Zn), amino acids of which two molecules for the first time - carnosine and PQQ - determine an antioxidant synergistic effect , anti-aging and neutralizing free radicals produced continuously in the human body, regulates cholesterol levels, protects the nervous system, protects eyesight, strengthens the immune system, with swarm in the prevention of degenerative diseases and cardiovascular diseases.
Invenția se referă la prepararea unui medicament sau supliment alimentar pentru prevenirea tulburărilor de stress oxidativ si nitroxativ, în special în cazurile în care peroxidarea lipidica este o componentă importanta a alterărilor biochimice (îmbătrânire, obezitate, chimioterapie, dislipidemîi, status inflamator cronic).The invention relates to the preparation of a medicament or dietary supplement for the prevention of oxidative and nitroxative stress disorders, especially in cases where lipid peroxidation is an important component of biochemical alterations (aging, obesity, chemotherapy, dyslipidemia, chronic inflammatory status).
Bibliographical dataBibliographical data
Antioxidantii sunt molecule care inhiba oxidarea altor molecule si apara organismul de efectele radicalilor liberi.Antioxidants are molecules that inhibit the oxidation of other molecules and protect the body from the effects of free radicals.
Radicalii liberi, produși fie prin metabolismul celular normal, fie ca efect al poluării si expunerii la alti factori externi, sunt responsabili de imbatranirea prematura a organismului si au rol in apariția bolilor cardiovasculare sau degenerative (cataracta, boala Alzheimer, cancerul). îmbătrânirea este factorul de risc primar în boala Alzheimer, pe măsura îmbătrânirii, după vârsta mijlocie (45-65 ani), mediul RedOx extracelular trece în status „oxidat”. Scade protecția tamponului RedOx mitocondrial, crește generarea (și concentrația) de specii reactive de oxigen (SRO), legate de disfuncția mitocondrială. Statusui oxidativ promovează neurodegenerarea; asigurarea generării de NADH la acest nivel ar fi o țintă terapeutică mai eficace înaintea GSH și generării SRO.Free radicals, produced either by normal cellular metabolism or as an effect of pollution and exposure to other external factors, are responsible for premature aging of the body and play a role in cardiovascular or degenerative diseases (cataracts, Alzheimer's disease, cancer). aging is the primary risk factor in Alzheimer's disease, as we age, after middle age (45-65 years), the extracellular RedOx environment changes to an "oxidized" status. Decreases mitochondrial RedOx buffer protection, increases the generation (and concentration) of reactive oxygen species (ORS) related to mitochondrial dysfunction. Oxidative status promotes neurodegeneration; ensuring the generation of NADH at this level would be a more effective therapeutic target before GSH and ORS generation.
Rol în organismRole in the body
Antioxidantii Împiedică procesul de îmbătrânire a celulelor din organism, datorita acțiunii împotriva radicalilor liberi, antioxidantii sunt si aliatii frumuseții, produsele anti-aging avana diverși antioxidant! pe lista de ingrediente: vitamina C, vitamina E, ceai verde, extract din semințe de struguri, coenzima Q10, SOD, etc.Antioxidants Prevent the aging process of cells in the body, due to the action against free radicals, antioxidants are also allies of beauty, anti-aging products have various antioxidants! on the list of ingredients: vitamin C, vitamin E, green tea, grape seed extract, coenzyme Q10, SOD, etc.
Beneficiile antioxidantelorThe benefits of antioxidants
Antioxidantii luptă cu radicalii liberi, reduc stresul oxidativ si încetinesc procesul de îmbătrânire: alte beneficii pentru organism:Antioxidants fight free radicals, reduce oxidative stress and slow down the aging process: other benefits for the body:
® reglează nivelul colesterolului * protejează sistemul nervos * protejează vederea a 2020 00173® regulates cholesterol levels * protects the nervous system * protects vision of 2020 00173
01/04/2020 ® întărește sistemul imunitar * previne bolile degenerative si bolile cardiovasculare * ajuta in tratamentul cancerului01/04/2020 ® strengthens the immune system * prevents degenerative diseases and cardiovascular diseases * helps in the treatment of cancer
Figura 1 legătura între oxi-inflamație-îmbătrânire și fragilitatea biochimică ante-boală și boală (preclinical and clinical fraiity). CVD, boala cardiovasculară [Liguori &al. 2018]Figure 1 link between oxy-inflammation-aging and biochemical fragility ante-disease and disease (preclinical and clinical fraiity). CVD, cardiovascular disease [Liguori & al. 2018]
Figura 2 implicarea speciilor reactive de oxigen în diferite forme de cancer - cancerul endometrial (după a 2020 00173Figure 2 Involvement of reactive oxygen species in various forms of cancer - endometrial cancer (after 2020 00173
01/04/202001/04/2020
Ingredientele ce intră în compoziția produsului au următoarele beneficii:The ingredients that make up the product have the following benefits:
CarnosinaCarnosine
Carnosina sau beta-alanil-histidina este un dipeptid endogen de mici dimensiuni care conține doi aminoacizi, beta-alanina si histidina izolată pentru prima oară în anul 1900 de Gulewitsch.Carnosine or beta-alanyl-histidine is a small endogenous dipeptide containing two amino acids, beta-alanine and histidine first isolated in 1900 by Gulewitsch.
Figura 3 Carnosina - befa-alanii-L-histidîne (denumire IUPAC (2S)-2-[(3-Amino-1oxopropyl)amino]-3-(3H-imidazol-4-yl) propanoic acidFigure 3 Carnosine-befa-alanyl-L-histidine (IUPAC (2S) -2 - [(3-Amino-1oxopropyl) amino] -3- (3H-imidazol-4-yl) propanoic acid
Se găsește în concentrații relativ mari în mai multe țesuturi ale corpului, in special in mușchii scheletici, in mușchii cardiaci si in creier. Lucrul remarcabil este ca acești doi aminoacizi funcționează mult mai eficient legați decât independent. In timp ce este inca combinata, carnosina este responsabilă pentru o serie de activități de detoxificare a radiccaliior liberi in special produși prin peroxidarea membranelor lipidice. Studii recente releva și faptul că această moleculă aro un roi protector ai membranelor celulare, capacitate tampon pentru protoni, formarea complexelor cu metale de tranziție și reglarea activității macrofagelor; carnosina are în organism abilitatea unică de a întineri celulele - pentru a face celulele vechi mai tinere si pentru a-si extinde ciclul de viata.It is found in relatively high concentrations in many tissues of the body, especially in skeletal muscle, heart muscle and brain. The remarkable thing is that these two amino acids work much more efficiently linked than independently. While still combined, carnosine is responsible for a number of free radical detoxification activities especially produced by peroxidation of lipid membranes. Recent studies also reveal that this molecule aro a protective swarm of cell membranes, buffer capacity for protons, the formation of complexes with transition metals and the regulation of macrophage activity; Carnosine has the unique ability to rejuvenate cells in the body - to make old cells younger and to extend their life cycle.
Carnosina are proprietăți antioxidante puternice si specifice, protejează împotriva radiațiilor, îmbunatateste funcția inimii si promovează recuperarea de ia răni. Recent a fost demonstrat potențialul carnitinei de a capta selectiv si puternic aldehîdele alfa si beta - produși de degradare în urma peroxidării lipidice a membranelor celulare sub atacul agentilor agresori (stress oxidativ si nitro-oxidativ ce generează ROSN - reactive oxîdative and nitrogen species) astfel carnosina inhibă cross-iinking-ul proteină - proteină și ADN-proteină în boii neurodegenerative (boala Alzheimer) alterările cardiomiociteior din boala ischemică cardiacă și în boli inflamatorii, BPOC, boala renală cronică și cancer. Produși! terminali de giicare (AGE) sunt markeri ai proceselor de îmbătrânire sau a proceselor metabolice degenerative ca diabetul, ateroscieroza, boala renală cronică, boala Alzheimer.Carnosine has strong and specific antioxidant properties, protects against radiation, improves heart function and promotes recovery from injuries. Recently, the potential of carnitine to selectively and strongly capture alpha and beta aldehydes - degradation products following lipid peroxidation of cell membranes under the attack of aggressors (oxidative and nitro-oxidative stress that generates ROSN - oxidative reagents and nitrogen species) has been demonstrated. inhibits protein-protein and DNA-protein cross-linking in neurodegenerative diseases (Alzheimer's disease) cardiomyocyte alterations in cardiac ischemic disease and in inflammatory diseases, COPD, chronic kidney disease and cancer. Products! Joking terminals (AGEs) are markers of aging processes or degenerative metabolic processes such as diabetes, atherosclerosis, chronic kidney disease, Alzheimer's disease.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Figura 4 Procesul de gheare. Formarea pirimidinei derivate din metiiglioxai și imidazolon Glicarea determină deseori modificarea porțiunii guanidină din reziduurile de arginină cu giioxal (R=H), metiiglioxai (R=Me) și 3-deoxiglucozona - ce derivă din dietele bogate în carbonidrați. Modificate aceste proteine contribuie la complicațiile diabetuluiFigure 4 The claw process. Formation of pyrimidine derived from methyloxai and imidazolone Glycation often alters the portion of guanidine in the residues of arginine with giioxal (R = H), methyllioxai (R = Me) and 3-deoxyglucosone - which is derived from carbohydrate-rich diets. Modified these proteins contribute to the complications of diabetes
AGE se formează predominant din hrana de origine animală și se formează în plus prin gătirea mâncării. Carnozina reduce rata de formare a produșilor terminali de gheare. Efectul antioxidant al carnosinei este atribuit efectului său de chelare a ionilor metalici din organism, activitate tio SOD și capacității de captare a radicalilor liberi.AGEs are formed predominantly from food of animal origin and are formed in addition by cooking food. Carnosine reduces the rate of formation of claw end products. The antioxidant effect of carnosine is attributed to its effect of chelating metal ions in the body, thio SOD activity and the ability to capture free radicals.
Figura 5 Stress oxidativ, boli legate de îmbătrânire și biomarkeri (4-HNE, trans-4-hydroxy-2nonenal; 8oxodG, 7,8-dihydro-8-oxo-2!-deoxyguanosine; 8oxoGuo, 7,8-dihydro-8oxoguanosine; ADMA, asymmetric dimethyl L-arginine; AGEs, advanced glycation end Products; CKD, chronic kidney disease; CVDs, cardiovascular diseases; F2-lsoPs, F2isoprostanes; MDA, malondialdehyde; MPO, myeloperoxidase; NDs, neurodegenerative diseases; NT, nitrotyrosine; oxLDL, oxidized low-density lipoprotein; PC, protein carbonyl; Prx, peroxiredoxins; P-VASP, phosphorylated vasodilator-stimulated phosphoprotein; Trx, thioredoxin. [Liguori &al. 2018]) a 2020 00173Figure 5 Oxidative stress, aging-related diseases and biomarkers (4-HNE, trans-4-hydroxy-2nonenal; 8oxodG, 7,8-dihydro-8-oxo-2 ! -Deoxyguanosine; 8oxoGuo, 7,8-dihydro-8oxoguanosine ; ADMA, asymmetric dimethyl L-arginine; AGEs, advanced glycation end Products; CKD, chronic kidney disease; CVDs, cardiovascular diseases; F2-lsoPs, F2isoprostanes; MDA, malondialdehyde; MPO, myeloperoxidase; NDs, neurodegenerative diseases; NT, nitrotyrosine; oxLDL, oxidized low-density lipoprotein; PC, carbonyl protein; Prx, peroxyredoxins; P-VASP, phosphorylated vasodilator-stimulated phosphoprotein; Trx, thioredoxin. [Liguori et al. 2018]) to 2020 00173
01/04/202001/04/2020
126 Camosina este prezentă în țesutul nervos și muscular uman în concentrații de până la 20 mM.126 Camosine is present in human nerve and muscle tissue in concentrations up to 20 mM.
128 Capacitatea acesteia de a neutraliza aldehidele toxice rezultate din cade metabolice de degradare oxidativă a compușilor endogeni ca și hidratii de carbon (glucide), acizi grași 130 nesaturați și proteine este implicată și în neutralizarea 4-hidroxi -2,3-nonenal (HNE) moleculă ce formează adducți cu biomacromolecule endogene racționând cu cisteina, lisina, 132 histidina din componența proteinelor endogene generând modificări structurale și conformaționale ce stau la baza alterărilor din procesele degenerative.128 Its ability to neutralize toxic aldehydes resulting from metabolic pathways of oxidative degradation of endogenous compounds such as carbohydrates (carbohydrates), 130 unsaturated fatty acids and proteins is also involved in the neutralization of 4-hydroxy -2,3-nonenal (HNE) molecule that forms adducts with endogenous biomacromolecules reacting with cysteine, lysine, 132 histidine in the composition of endogenous proteins generating structural and conformational changes that underlie the alterations in degenerative processes.
Αβ-ollgomersΑβ-ollgomers
Acrolein 4-hydroxy-2,3-nor3enal MaîondiaidehydeAcrolein 4-hydroxy-2,3-nor3enal Mayondiaidehyde
împaired Reduced gîucose axonai transport metabolismReduced glucose axon transport metabolism
Reduced antioxidant detensesReduced antioxidant detenses
Reduced ATP productionReduced ATP production
oxida ti ve stress synaptic funcîionoxidize your synaptic stress function
134134
Figura 6 Modelul redox in patogeneza bolii Alzheimer. Beta peptidul amiloid (Αβ) generat 136 prin clivarea proteolitică prin secretaze a proteinei precursoare de amiloid (APP) ce se inseră în membrana celulară (neuronală) vor induce peroxidarea lipidică cu formarea 138 produșilor de lipooxidare printre care și 4-HO-2,3-nonenal - cu cea mai intensă activitate biologică, acroleină - specia cea mai reactivă și metil malon aldehidă - metaboliți toxici 140 generați endogen (20).Figure 6 Redox model in the pathogenesis of Alzheimer's disease. Beta amyloid peptide (Αβ) generated 136 by proteolytic cleavage by secretase of amyloid precursor protein (APP) that is inserted into the cell membrane (neuronal) will induce lipid peroxidation with the formation of 138 lipid oxidation products including 4-HO-2,3 -nonenal - with the most intense biological activity, acrolein - the most reactive species and methyl malon aldehyde - toxic metabolites 140 endogenously generated (20).
a 2020 00173and 2020 00173
01/04/202001/04/2020
Pirolochinolina Quinonă (PQQ)Pyrroloquinoline Quinone (PQQ)
Este un cofactor redox natural găsit în sol sau în alimentele- fructul kiwi, soia fermentat[ cu natto, ceai, ardei verde, pătrunjel sau laptele de sân (uman). Enzimele ce conțin PQQ sunt denumite quino-proteine de exemplu dehidrogenaza glucozei (GDH) utilizată și ca senzor de glucoza. A fost descoperită de J G Hauge ca al treilea cofactor redox după nicotinamida (NAD) și flavina în bacterii. Anthony, Zatman a identificat cofactorul redox PQQ în alcool dehidrogenaza și Saiisbury și Duine au identificat structura sa moleculară în 1979.It is a natural redox cofactor found in the soil or in food - kiwi fruit, fermented soy with natto, tea, green pepper, parsley or (human) breast milk. Enzymes containing PQQ are called quino-proteins for example glucose dehydrogenase (GDH) also used as a glucose sensor. It was discovered by J G Hauge as the third redox cofactor after nicotinamide (NAD) and flavin in bacteria. Anthony, Zatman identified the redox cofactor PQQ in alcohol dehydrogenase and Saiisbury and Duine identified its molecular structure in 1979.
Figura Ί Structura chimică - Pirolochinolina Quinonă (ACD/ChemSketch 10.0 & Inkscape)Figure Ί Chemical structure - Quinoa pyrroloquinoline (ACD / ChemSketch 10.0 & Inkscape)
PQQ pqqh2 PQQ pqqh 2
Figura 8 reacția redox cu substrat PQQFigure 8 redox reaction with PQQ substrate
Poziționată inițial ca vitamină B (Kasahara, Nature 2003) o lucrare publicată în lucrările Academiei naționale de Științe a identificat PQQ ca o ‘vitamină’ a longevității dar neesențială supraviețuirii însă necesară pentru sănătatea pe termen lung (22) ca vitamină a longevității. Astfel, PQQ a devenit recent un subiect de interes printre nutriționiști și specialiștii în longevitate. Studii nutriționale au prezentat faptul că deficiențe nutriționale în PQQ la șoareci si șobolani se manifestă în moduri diferite incluzând deficite în creștere, deficite în răspunsul imun, performanță redusă de reproducere și tulburări ale performanței respiratorii PQQ activează căi în organism, care pot promova metabolismul energetic celular. Ca un antioxidant puternic, PQQ protejează și mărește funcționalitatea mitocondriilor existente. - încetinește îmbătrânirea mitocondrială.Initially positioned as vitamin B (Kasahara, Nature 2003), a paper published in the National Academy of Sciences identified PQQ as a ‘vitamin’ of longevity but not essential for survival but necessary for long-term health (22) as a vitamin of longevity. Thus, PQQ has recently become a topic of interest among nutritionists and longevity specialists. Nutritional studies have shown that nutritional deficiencies in PQQ in mice and rats manifest in different ways including growth deficits, immune response deficits, poor reproductive performance, and respiratory performance disorders. PQQ activates pathways in the body that can promote cellular energy metabolism. . As a powerful antioxidant, PQQ protects and enhances the functionality of existing mitochondria. - slows down mitochondrial aging.
PQQ promovează, de asemenea, generarea de noi miîocondrii (biogenesis mitocondrial).PQQ also promotes the generation of new myochondria (mitochondrial biogenesis).
a 2020 00173and 2020 00173
01/04/202001/04/2020
- Creșterea mitocondriilor = creșterea producției de energie, din acest motiv, este considerat un compus activ anti-îmbătrânire.- Increased mitochondria = increased energy production, for this reason, is considered an active anti-aging compound.
in forma redusă activitatea de neutralizare a radicalilor aroxil liberi este de 7,4 ori mai mare față de cea a vitaminei C fiind cei mai activ antioxidant din organism în forma sa hidrosolubilă. Studii arată că PQQ amplifică funcțiile mitocondriale, induce regenerarea neuronilor si acelulelor nervoase, mențin funcția neuronală și fertilitatea (24). In forma redusă activitatea de neutralizare a radicalilor. PQQ prezintă un rol protector în activitatea glandei parotide, ficat, rinichi și țesut osos prin inhibarea stresului oxidativ și alterarea ADN în urma expunerii la agenți agresori (25) și recent s-a demonstrat că PQQ are un efect inhibitor asupra diferențierii osteoclasteior in vitro (26) și previne osteoporoza indusă de deficitul de estrogen prin inhibarea stresului oxidativ și inhibarea senescenței osteocitelor (Qinghe Geng, 2019) și previne osteoartrita genunchiului pe modelele animale (Qin, 2019) (27)in the reduced form, the neutralizing activity of free aroxyl radicals is 7.4 times higher than that of vitamin C being the most active antioxidant in the body in its water-soluble form. Studies show that PQQ amplifies mitochondrial functions, induces the regeneration of neurons and nerve cells, maintains neuronal function and fertility (24). In the reduced form the radical neutralization activity. PQQ has a protective role in the activity of the parotid gland, liver, kidney and bone tissue by inhibiting oxidative stress and DNA alteration following exposure to aggressors (25) and PQQ has recently been shown to have an inhibitory effect on osteoclast differentiation in vitro (26) and prevents estrogen deficiency-induced osteoporosis by inhibiting oxidative stress and inhibiting osteocyte senescence (Qinghe Geng, 2019) and prevents knee osteoarthritis in animal models (Qin, 2019) (27)
PQQ nu prezintă toxicitate și genotoxicitate (28) la administrarea orală deci suplimentarea cu PQQ este un mod promițător pentru îmbunătățirea statusului de sănătate în cursul proceselor dismetabolice, inflamatori: sau legate de șenescență.PQQ does not show toxicity and genotoxicity (28) when administered orally so supplementation with PQQ is a promising way to improve health status during dysmetabolic, inflammatory: or senescence-related processes.
Coenzima Q10Coenzyme Q10
Este un antioxidant care ajuta sistemul imunitar, sistemul nervos si activitatea inimii si care reduce semnele Îmbătrânirii. Odata cu înaintarea in varsta, organismul cataiizeaza tot mai greu coenzima Q10, dar o putem lua din suplimente si alimente precum pestele gras, carnea de pui si de vita, nuci si semințe.It is an antioxidant that helps the immune system, nervous system and heart activity and reduces the signs of aging. As we age, the body becomes more difficult to coenzyme Q10, but we can take it from supplements and foods such as fatty fish, chicken and beef, nuts and seeds.
Extract de biocurcumin din turmericTurmeric biocurcumin extract
Curcuma este o planta care se înrudește cu ghimbîrul si reprezintă de fapt un gen din care fac parte in jur de 100 de specii de plante perene, din familia Zingiberaceae. Aceasta planta este originara din sudul Asiei si nordul Australiei, fiind folosita cu precădere în India, de peste 4000 de ani, datorita proprietăților sare terapeutice. Turmerîcul (Curcuma longa) reprezintă una dintre speciile de curcuma, fiind cunoscut si sub denumirea de sofran indianTurmeric is a plant that is related to ginger and is actually a genus that includes about 100 species of perennials in the family Zingiberaceae. This plant is native to South Asia and northern Australia, being used mainly in India for over 4000 years, due to its therapeutic salt properties. Turmeric (Curcuma longa) is one of the species of turmeric, being also known as Indian saffron.
Turmerîcul a fost îndelung utilizat in medicina ayurvedica (medicina tradiționala indiana), dar si in medicina chineza tradiționala, datorita numeroaselor sale proprietăți terapeutice. Beneficiile sunt datorate substanței active din turmeric, curcumin, care ajuta la tratarea infiamatiilor.Turmeric has long been used in Ayurvedic medicine (traditional Indian medicine), but also in traditional Chinese medicine, due to its many therapeutic properties. The benefits are due to the active substance in turmeric, curcumin, which helps treat inflammation.
* Ajuta la imbunatatirea memoriei - in cateva studii realizate pe populațiile din Asia a fost demonstrat faptul ca persoanele care au consumat mai mult curry au obtinut rezultate mai bune la testele de evaluare cognitiva fata de cele care nu au consumat acest condiment. Cercetătorii au corelat acest beneficiu cu turmerîcul, care este unul a 2020 00173* Helps improve memory - several studies of Asian populations have shown that people who ate more curry scored better on cognitive tests than those who did not eat this spice. The researchers correlated this benefit with turmeric, which is one of 2020 00173
01/04/2020 dintre ingredientele principale ale acestui amestec de condimente, dar si din alimentația asiaticilor. Totodată, cercetătorii cred ca efectele antiinfiamatorii ale curcuminului pot proteja creierul împotriva bolilor degenerative si pot preveni apariția bolii Alzheimer.01/04/2020 among the main ingredients of this spice mixture, but also from the Asian diet. At the same time, researchers believe that the anti-inflammatory effects of curcumin can protect the brain against degenerative diseases and can prevent Alzheimer's disease.
» Rol antiinflamator si antioxidant - unul dintre cele mai importante beneficii ale curcuminului este capacitatea de a reduce inflamatiile prin blocarea anumitor enzime implicate in acest proces. Totodată, efectul sau antioxidant ajuta ia prevenirea artritei, astmului sau bolilor inflamatorii intestinale.»Anti-inflammatory and antioxidant role - one of the most important benefits of curcumin is the ability to reduce inflammation by blocking certain enzymes involved in this process. At the same time, its antioxidant effect helps prevent arthritis, asthma or inflammatory bowel disease.
* Imbunatateste procesul de detoxificare - datorita proprietăților antioxidante, curcuminul ajuta la menținerea sanatatii organismului si stimulează enzimele care combat radicalii liberi, responsabili pentru deteriorarea celulelor si a ADN-ului;* Improves the detoxification process - due to its antioxidant properties, curcumin helps maintain the body's health and stimulates enzymes that fight free radicals, responsible for damaging cells and DNA;
Resveratrol (Polygonum Cuspidatum)Resveratrol (Polygonum Cuspidatum)
Resveratrolul se găsește în mod natural în struguri, fragi, alune, în vinul roșu, precum și în rădăcinile și ramurile de Polygonum cuspidatum, o plantă populară utilizată de foarte mult timp în medicina asiatică. Cojile speciilor de fructe roșii și negre sunt bogate în resveratrol, un derivat de stilben. Studiile au demonstrat că resevratrolul posedă proprietăți antioxidante, reduce riscul afecțiunilor cardiovasculare, previne apariția cancerului, reduce efectele plasmatice ale triglicerideior și colesterolului.Resveratrol is naturally found in grapes, strawberries, hazelnuts, red wine, as well as in the roots and branches of Polygonum cuspidatum, a popular plant used for a long time in Asian medicine. The shells of red and black fruit species are rich in resveratrol, a derivative of stilben. Studies have shown that resevratrol has antioxidant properties, reduces the risk of cardiovascular disease, prevents cancer, reduces the plasma effects of triglycerides and cholesterol.
Resveratrolul are următoarele efecte:Resveratrol has the following effects:
- protector hepatic și cardiovascular;- hepatic and cardiovascular protector;
- antioxidant;- antioxidant;
- anti-îmbătrânire;- anti-aging;
- anticelulitic;- anti-cellulite;
- crește tonusul și elasticitatea pielii;- increases skin tone and elasticity;
- întărește sistemul imunitar;- strengthens the immune system;
- adjuvant în terapiile antitumoraie.- adjuvant in antitumor therapies.
« Datorită acțiunii sale antioxidante, de 20 de ori mai mare decât a vitaminei C și de 50 de ori mai mare decât a vitaminei E, resveratrolul a crescut durata de viață a 60% din organismele studiate în cercetări de laborator.«Due to its antioxidant action, 20 times higher than vitamin C and 50 times higher than vitamin E, resveratrol has increased the lifespan of 60% of the organisms studied in laboratory research.
* Resveratrolul inhibă proliferarea la o varitate de celule canceroase: la cancerul mamar, de prostată, stomac, colon, pancreatic și respectiv tiroidian. în studiile efectuate pe animale s-a observat inhibarea creșterii celulelor implicate în cancerul mamar, esofagian și intestinal prin administrarea de resveratrol pe cale orală.* Resveratrol inhibits the proliferation of a variety of cancer cells: breast, prostate, stomach, colon, pancreatic and thyroid cancer. In animal studies, inhibition of cell growth involved in breast, esophageal and intestinal cancer by oral resveratrol has been observed.
Acid alfa lipoicAlpha lipoic acid
Este unul dintre cei mai importanti antioxidanți. Este implicat in producția de energie la nivel celular, protejează celulele de acțiunea radicalilor liberi, poate fi ușor transportat către creier, a 2020 00173It is one of the most important antioxidants. It is involved in the production of energy at the cellular level, protects cells from the action of free radicals, can be easily transported to the brain, 2020 00173
01/04/2020 dar are si capacitatea de a stimula producția altor antioxidant! in organism (glutation, coenzima Q10).01/04/2020 but it also has the ability to stimulate the production of other antioxidants! in the body (glutathione, coenzyme Q10).
Acidul lipoic (AL) este un acid gras cunoscut și sub numele de: acid α-lipoic și acid alfa lipoic (AAL) și acid tioctic, este un compus organosulfat, derivat din acidul octanoic. Descoperit în anii 1980, acidul alfa-lipoic a fost inițial clasificat ca o vitamină.Lipoic acid (AL) is a fatty acid also known as: α-lipoic acid and alpha lipoic acid (AAL) and thioctic acid, is an organosulfate compound, derived from octanoic acid. Discovered in the 1980s, alpha-lipoic acid was originally classified as a vitamin.
Acidul alfa lipoic se găsește, în mod natural, în fiecare celulă a corpului (este sintetizat de organismul uman, însă în cantități mici), implicată în metabolismul energetic al proteinelor, carbohidratilor si Grăsimilor, având o outernică acțiune antioxidantă.Alpha lipoic acid is found naturally in every cell of the body (it is synthesized by the human body, but in small quantities), involved in the energy metabolism of proteins, carbohydrates and fats, having a great antioxidant action.
Acidul alfa lipoic protejează structura nervilor afectați de neuropatii, inclusiv de neuropatia diabetică. Acesta neutralizează radicalii liberi atât în zonele grase, cât și cele lichide ale celulei, în comparație cu vitamina C care este solubilă doar în apă și vitamina E care este solubilă doar în grăsimi.Alpha lipoic acid protects the structure of nerves affected by neuropathies, including diabetic neuropathy. It neutralizes free radicals in both fatty and liquid areas of the cell, compared to vitamin C which is soluble only in water and vitamin E which is soluble only in fat.
PycnogenolPycnogenol
Pycnogenol-ul reprezintă un extract patentat din scoarța de pin maritim, compus dintr-un amestec de bioflavonoide active. Cei peste 40 de ani de cercetări in domeniu, au fost dedicati, stabilirii siguranței si a beneficilor asupra sanatatii si s-au concluzionat in peste 100 de studii clinice si peste 300 de lucrări științifice.Pycnogenol is a patented extract of sea pine bark, composed of a mixture of active bioflavonoids. The over 40 years of research in the field have been dedicated to establishing safety and health benefits and have been concluded in over 100 clinical trials and over 300 scientific papers.
» Rol antioxidant»Antioxidant role
65-75% dintre componentele active ale PYC sunt reprezentate de procianidine, mai exact catechina si epicatechina, iar restul de 35-25% este reprezentat de monomeri polifenolici, acizi fenoiici sau cinamici si glicozidele lor, toate acestea avand o biodisponibilitate ridicata. Combinația de ingrediente bioactive, are efecte biiogice mult mai puternice fata de extractul purificat al fiecărui component in parte, ceea ce indica efectul sinergie al acestora.65-75% of the active components of PYC are represented by procyanidins, more precisely catechin and epicatechin, and the remaining 35-25% is represented by polyphenolic monomers, phenolic or cinnamic acids and their glycosides, all of which have a high bioavailability. The combination of bioactive ingredients has much stronger biological effects than the purified extract of each component, which indicates their synergistic effect.
Datorita compoziției (acizi fenoiici, polifenoli si in special flavonoidele), PYC este un antioxidant eficace, ajutand la reducerea nivelurilor radicalilor liberi. Astfel s-a demonstrat ca administrarea a 50mg PYC, pe o durata de 8 saptamani, la un grup de 78 de fumători, ajuta la reducerea concentrațiilor plasmatice ale speciilor reactive de oxigen.Due to its composition (phenolic acids, polyphenols and especially flavonoids), PYC is an effective antioxidant, helping to reduce free radical levels. Thus, it has been shown that the administration of 50 mg of PYC, for a period of 8 weeks, to a group of 78 smokers, helps to reduce the plasma concentrations of reactive oxygen species.
CarnitinăCarnitine
L-Carnitina este sintetizata in organism din aminoacizii lizina si metionina.L-Carnitine is synthesized in the body from the amino acids lysine and methionine.
L-Carnitina este un aminoacid eficient pentru arderea grăsimilor. Aceasta transfera acizii grași cu catena lunga in mitocondrii, unde sunt oxidați si produc energie.L-Carnitine is an effective amino acid for burning fat. It transfers long-chain fatty acids to the mitochondria, where they are oxidized and produce energy.
Antioxidant cu acțiune dublă și un aminoacid cunoscut pentru protecția celulelor nervoase. De asemenea, înlesnește comunicarea creierului, eliminând ravagiile produse de radicalii liberi la nivelul acestuia.Dual-acting antioxidant and an amino acid known to protect nerve cells. It also facilitates the communication of the brain, eliminating the ravages produced by free radicals in it.
a 2020 00173and 2020 00173
01/04/202001/04/2020
ÂstaxantinăStaxanthin
Astaxantina este un compus din categoria carotenoizilor, aceasta este responsabilă parțial de culoarea portocalie a somonului și a altor vietăți acvatice.Astaxanthin is a compound in the category of carotenoids, it is partly responsible for the orange color of salmon and other aquatic life.
Organismul uman nu poate sintetiza astaxantina. în general acest compus nu este transformat de organism în vitamina A, totuși, în cazuri severe de carență, aceasta transformare poate avea loc.The human body cannot synthesize astaxanthin. In general, this compound is not converted by the body into vitamin A, however, in severe cases of deficiency, this transformation can take place.
Astaxantina nu este un nutrient esențial, dar consumul alimentelor bogate în astaxantina poate avea efecte benefice asupra organismului. Ca și ceilalți carotenoizi, astaxantina este un antioxidant puternic, chiar mai puternic decât ceilalți carotenoizi și decât vitamina A. Efecte:Astaxanthin is not an essential nutrient, but eating foods rich in astaxanthin can have beneficial effects on the body. Like other carotenoids, astaxanthin is a powerful antioxidant, even stronger than other carotenoids and vitamin A. Effects:
* Reduce ridurile și estompează petele „de bătrânețe”.* Reduces wrinkles and fades "old age" stains.
* îmbunătățește fermitatea și textura pielii.* Improves skin firmness and texture.
* Protejează pielea din interior de efectele razelor ultraviolete.* Protects the skin from the inside from the effects of ultraviolet rays.
» Crește nivelul de energie și îmbunătățește atenția și concentrarea.»Increases energy levels and improves attention and concentration.
* Susține rezistența fizică și recuperarea după efort.* Supports physical endurance and recovery after exertion.
* Contribuie la protejarea vederii și articulațiilor.* Helps protect eyesight and joints.
Extract de ceai verde standardizat la 50% polifenohGreen tea extract standardized to 50% polyphenols
Ceaiul verde provine din frunzele plantei Camellia sinensis si este utilizat de către chinezi de mai bine de 2.000 de ani, datorita numeroaselor proprietăți terapeutice de care dispune aceasta planta. Este unul dintre cele mai renumite surse de poiifenoli cu proprietăți antioxidante.Green tea comes from the leaves of the plant Camellia sinensis and has been used by the Chinese for more than 2,000 years, due to the many therapeutic properties of this plant. It is one of the most famous sources of polyphenols with antioxidant properties.
încă din Antichitate, ceaiul verde a fost folosit ca un remediu eficient in ameliorarea durerilor de cap, pentru o buna stare de spirit si ca energizant.Since antiquity, green tea has been used as an effective remedy in relieving headaches, for a good mood and as an energizer.
Astăzi, cercetările științifice atesta proprietățile deosebite si confirma beneficiile pe care consumul de ceai verde le aduce in viata noastra atat ia nivel fizic, cat si mental sau spiritual.Today, scientific research attests to the special properties and confirms the benefits that the consumption of green tea brings to our lives both physically and mentally or spiritually.
* Are efect diuretic si detoxifiant. Ceaiul verde ajuta buna funcționare a rinichilor si previne retentia de apa. Ajuta ia activarea metabolismului, regieaza tranzitul intestinal, stimulează ficatul si întregul sistem digestiv, asigurând astfel detoxifierea organismului.* It has a diuretic and detoxifying effect. Green tea helps the kidneys function well and prevents water retention. It helps activate the metabolism, regulates the intestinal transit, stimulates the liver and the entire digestive system, thus ensuring the detoxification of the body.
• Bogat in antioxidant!. Beneficiile asupra sanatatii pe care extractul de ceai verde le are se datoreaza in mare parte conținutului sau antioxidant ridicat.• Rich in antioxidants !. The health benefits that green tea extract has are largely due to its high antioxidant content.
« încetinește imbatranirea. Ceaiul verde combate efectele poluării datorita antioxidantilor pe care ii conține. Lupta împotriva radicalilor liberi produși de diverse noxe: fum de țigara, gaze de eșapament sî de raze ultraviolete; care îmbătrânesc organismul înainte de vreme.«Slows down aging. Green tea combats the effects of pollution due to the antioxidants it contains. Fight against free radicals produced by various noxious substances: cigarette smoke, exhaust fumes and ultraviolet rays; which age the body prematurely.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Vitamina B2Vitamin B2
Vitamina B2 sau riboflavina este una dintre cele opt vitamine apartinand complexului B. Toate contribuie ia transformarea carbohidratilor in glucoza, folosita ulterior de către organism ca energie. Toate vitaminele din grupul B sunt hidrosolubde. Astfel, organismul nu este capabil sa le stocheze, pentru a le folosi mai târziu.Vitamin B2 or riboflavin is one of the eight vitamins belonging to the B complex. All contribute to the transformation of carbohydrates into glucose, which is then used by the body as energy. All B vitamins are water soluble. Thus, the body is not able to store them for later use.
Riboflavina funcționează ca un antioxidant, contribuie la protecția organismului împotriva particulelor daunatoare cunoscute sub numele de radicali liberi. Aceștia afecteaza celulele si ADN-ul si grăbesc procesul de îmbătrânire, dar si apariția unor afecțiuni cardiace sau tumorale.Riboflavin works as an antioxidant, helping to protect the body against harmful particles known as free radicals. They affect cells and DNA and speed up the aging process, but also the appearance of heart or tumor diseases.
Vitamina CC vitamin
Vitamina C este o substanță importantă pentru dezvoltarea și menținerea sănătății organismului.Vitamin C is an important substance for developing and maintaining the health of the body.
Printre altele, vitamina C are un rol important în răspunsul imunitar la stres și ia infecțiile virale și bacteriene (deoarece participă la formarea anticorpilor și interferonilor).Among other things, vitamin C plays an important role in the immune response to stress and takes viral and bacterial infections (because it participates in the formation of antibodies and interferons).
Stările de deficit de vitamina C pot apărea datorită unei diete inadecvate, din care lipsesc fructele și legumele, dar sunt rareori întâlnite la aduiți, aparând în special la copii, alcoolici și vârstnici. Stresul, expunerea la frig, exercițiile fizice de performanță duc la o creștere a proceselor oxidative ale plasmei, astfel fiind necesară suplimentarea cu vitamina C.Vitamin C deficiency can occur due to an inadequate diet, which lacks fruits and vegetables, but are rarely found in adults, especially in children, alcoholics and the elderly. Stress, exposure to cold, performance exercise lead to an increase in oxidative processes of plasma, so it is necessary to supplement with vitamin C.
Implicată în formarea și regenerarea globulelor roșii, a oaselor și a țesuturilor, vitamina C contribuie la întărirea vaselor de sânge, ajută la menținerea sănătății gingiilor și la vindecarea mai rapidă a rănilor, luptă contra infecțiilor și întărește sistemul imunitar. De asemenea, vitamina C are rol antioxidant, protejând celulele organismului de acțiunea radicalilor liberi, ajută organismul să absoarbă fierul, contribuie la producția de hormoni și reglează funcția nervoasă.Involved in the formation and regeneration of red blood cells, bones and tissues, vitamin C helps strengthen blood vessels, helps maintain healthy gums and faster wound healing, fights infections and strengthens the immune system. Vitamin C also has an antioxidant role, protecting the body's cells from the action of free radicals, helps the body absorb iron, contributes to the production of hormones and regulates nerve function.
Vitamina C activează numeroase enzime și joacă un rol important în respirația celulară, accelerează procesul de vindecare a rănilor, fiind implicată în producerea colagenului și protejează împotriva apariției cancerului, stopând formarea nîtrozaminelor (agenți cancerigeni care se formează în timpul asimilării aminoacizior în stomac).Vitamin C activates many enzymes and plays an important role in cellular respiration, accelerates wound healing, is involved in collagen production and protects against cancer, stopping the formation of nitrosamines (carcinogens that form during the assimilation of amino acids in the stomach).
Vitamina C se absoarbe bine din tubul digestiv. Absorbția este diminuată la cei cu hipoaciditate sau cu tranzit intestinal accelerat. La nivel intestinal, absorbția vitaminei C se realizează împotriva gradientului de concentrație, prin intermediul unui sistem de transport specific (transport activ). în cazul administrării unor doze mari de vitamina C, absorbția intestinală se realizează prin transport pasiv (difuzie). Capacitatea maximă de de absorbție intestinală este limitată la 1200 mg în 24 de ore, la o doză de 3 g/zî. Concentrația plasmatică fiziologică este de 0,7 - 1 pg/100 ml.Vitamin C is well absorbed from the digestive tract. Absorption is decreased in those with hearing loss or accelerated intestinal transit. At the intestinal level, the absorption of vitamin C is achieved against the concentration gradient, through a specific transport system (active transport). In case of administration of high doses of vitamin C, intestinal absorption is achieved by passive transport (diffusion). The maximum intestinal absorption capacity is limited to 1200 mg in 24 hours at a dose of 3 g / day. The physiological plasma concentration is 0.7 - 1 pg / 100 ml.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Vitamina C prezintă de asemenea marele avantaj de a nu se acumula in organism și deci de a nu prezenta vreun pericol de supradozare sau toxicitate (LD50 pentru șobolani este de 11900 mg/kg), permițând astfel utilizarea ei fără restricții.Vitamin C also has the great advantage of not accumulating in the body and therefore not presenting any danger of overdose or toxicity (LD 50 for rats is 11900 mg / kg), thus allowing its use without restrictions.
Vitamina EVitamin E
Vitamina E, denumită și “vitamina fertilității, a fost descoperită în germenii de grâu, în 1922.Vitamin E, also called “fertility vitamin, was discovered in wheat germ in 1922.
Aceasta reprezintă o familie de 8 componente antioxidante: 4 tocoferoli și 4 tocotrienoli, fiecare alfa, beta, gama, delta. Forma alfa-tocoferol se găsește în cantități mari în sânge și țesuturi și este mult superioară față de activitatea celorlalte forme de vitamina E. Vitamina E este un constituent ai membranelor celulare care, în principal, sunt formate din grăsimi sensibile la fenomenul de oxidare. Tocoferolii exercită o acțiune de stabilizare a membranelor celulare prin influențarea vâscozității permeabilității și flexibilității peretelui celular. Protejându-ne celulele, vitamina E ne protejează sistemul imunitar.It represents a family of 8 antioxidant components: 4 tocopherols and 4 tocotrienols, each alpha, beta, gamma, delta. The alpha-tocopherol form is found in large amounts in the blood and tissues and is far superior to the activity of other forms of vitamin E. Vitamin E is a constituent of cell membranes that are mainly composed of fats sensitive to oxidation. Tocopherols exert a stabilizing action on cell membranes by influencing the viscosity of the permeability and flexibility of the cell wall. By protecting our cells, vitamin E protects our immune system.
Este un puternic antioxidant. Joacă un rol Important împotriva îmbătrânirii.It is a powerful antioxidant. It plays an important role against aging.
CupruCopper
Esențial în prevenirea bolilor cardiovasculare, în menținerea sănătății pielii și a culorii părului și în creșterea fertilității, cuprul se găsește în cel puțin 15 proteine din corpul omenesc. Cuprul este esențial în formarea colagenului, o proteină de baza din oase, piele și țesutul conjunctiv. El joacă un rol important în dezvoltarea globulelor roșii ale sângelui, poate ajuta organismul să folosească fierul înmagazinat și poate să crească imunitatea și fertilitatea. Implicat în sintetizarea melaninei (pigmentul natural care se găsește în păr, piele și ochi), cupru! ajută și la o bună pigmentare. Cuprul este necesar pentru sintetizarea multor enzime, și în special superoxid dismutaza (SOD), care pare să fie unui dintre antioxidanții cei mai puternici ai organismului. Poate preveni și pierderea de masă osoasă care poate duce la osteoporoza.Essential in preventing cardiovascular disease, maintaining healthy skin and hair color and increasing fertility, copper is found in at least 15 proteins in the human body. Copper is essential in the formation of collagen, a basic protein in bones, skin and connective tissue. It plays an important role in the development of red blood cells, can help the body use stored iron and can increase immunity and fertility. Involved in the synthesis of melanin (the natural pigment found in hair, skin and eyes), copper! it also helps with good pigmentation. Copper is needed for the synthesis of many enzymes, and especially superoxide dismutase (SOD), which appears to be one of the body's most powerful antioxidants. It can also prevent bone loss that can lead to osteoporosis.
ZinculZinc
- sub formă de oxid de zinc, are o mare importanta in buna funcționare a organismului uman, fiind un mineral cu multe valențe terapeutice. El s-a dovedit eficient in: creșterea imunității, raceala, degenerescenta maculara, vindecarea leziunilor sau ADHD.- in the form of zinc oxide, it has a great importance in the good functioning of the human body, being a mineral with many therapeutic valences. It has been shown to be effective in: increasing immunity, colds, macular degeneration, wound healing or ADHD.
Zincul este vital pentru sanatatea noastra. Acestui microeiement ii revin nenumărate roiuri in reacțiile metabolice: participa la peste 300 de reacții enzimatice ale metabolismului celular si se regăsește in conținutul altor 50 de enzime. Zincul este important pentru creștere si dezvoltare, pentru regenerarea celulara, pentru producția de sperma si sistemul imunitar, stocarea de insulina si sinteza proteinelor, Zincul contribuie la:Zinc is vital to our health. This microelement has countless swarms in metabolic reactions: it participates in over 300 enzymatic reactions of cellular metabolism and is found in the content of another 50 enzymes. Zinc is important for growth and development, for cell regeneration, for sperm production and the immune system, insulin storage and protein synthesis, Zinc contributes to:
a 2020 00173and 2020 00173
01/04/2020 rz menținerea fertilității și reproducerii normale,01/04/2020 r z maintaining normal fertility and reproduction,
376 - menținerea concentrațiilor normale de testosteron din sânge.376 - maintaining normal blood testosterone levels.
Exista studii care susțin teoria conform careia exista o legătură intre integritatea sistemuluiThere are studies that support the theory that there is a link between system integrity
378 imunitar si cantitatea de zinc din organism. Acest mineral ajuta la reglarea nivelului de limfocite T, limfocitelelor T CD4 si interieukinei-2. Acest rol in cadrul sistemului imunitar ii378 immune and the amount of zinc in the body. This mineral helps regulate the level of T lymphocytes, CD4 T lymphocytes and interieukin-2. This role in the immune system ii
380 oferă zincului capacitatea de a facilita vindecarea rănilor. Alte studii au aratat ca modificările nivelului de zinc din organism pot modifica apoptoza, in prezent cunoscuta ca “moartea380 gives zinc the ability to facilitate wound healing. Other studies have shown that changes in the level of zinc in the body can alter apoptosis, now known as “death
382 celulara programata”. De asemenea, s-a demonstrat ca zincul poseda proprietăți antiinflamatoare.382 scheduled cell phone ”. Zinc has also been shown to have anti-inflammatory properties.
384 Aportul zilnic de zinc prin alimentație este necesar deoarece corpul nu are posibilitatea de stocare a zincului. Specialiștii nutritionisti si dieteticienii recomanda un aport zilnic de zinc de384 Daily dietary intake of zinc is necessary because the body does not have the ability to store zinc. Nutritionists and dietitians recommend a daily intake of zinc
386 aproximativ 15 mg si de 25mg pentru femeile gravide sau cele care alaptează. Stresul sau sarcinile sporite, la care este supus corpul, cresc necesarul de zinc, iar in aceste situatii se386 approximately 15 mg and 25 mg for pregnant or lactating women. Increased stress or loads, to which the body is subjected, increase the need for zinc, and in these situations
388 recomanda un consum sporit, in plus, sportivii, persoanele in vârsta, pacientii care suferă de diabet, femeile care consuma preparate cu estrogen si persoanele care consuma in mod388 recommends increased consumption, in addition, athletes, the elderly, patients with diabetes, women who consume estrogen preparations and people who consume
390 regulat alcool, trebuie sa asigure un aport suficient de zinc.390 regular alcohol, must ensure a sufficient intake of zinc.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Avantajul formulei de obținere a produsului AGE MANAGEMENT AOX cu L-Carnosină, Pirolochinolina Quinonă (PQQ), resveratrol, astaxantina, picnogenol, curcumina, epigalocatechingalat (din Camelia sinensis) coenzima Q10, acid alfa iipoic, carnitina, citamina B2, vitamina C, vitamina E, cupru și zinc este că include două molecule antioxidanteni, o combinație complexă de componente bioactive de origine naturală, nutrienți cu rol sinergie antioxidant, reparator celular: Vitamina C contribuie la funcționarea normală a sistemului imunitar și la formarea normală a colagenului pentru funcționarea normală a pielii, împreună cu Vitamina E, Vitamina B2 și Zincul contribuie la protejarea celulelor împotriva stresului oxidativ; Cuprul contribuie la protejarea constituenților celulari împotriva stresului oxidativ. Zincul și Vitamina B2 contribuie la menținerea sănătății pielii. AGE MANAGEMENT AOX este recomandat persoanelor peste 40 de ani, afectate cumulativ de distrugerile la nivel celular.The advantage of the formula for obtaining the product AGE MANAGEMENT AOX with L-Carnosine, Pyrroloquinoline Quinone (PQQ), resveratrol, astaxanthin, pycnogenol, curcumin, epigallocatechingalate (from Camelia sinensis) coenzyme Q10, alpha iipoic acid, vitamin C, vitamin B2 E, copper and zinc is that it includes two antioxidant molecules, a complex combination of bioactive components of natural origin, nutrients with antioxidant synergistic role, cell repairer: Vitamin C contributes to the normal functioning of the immune system and the normal formation of collagen for the normal functioning of skin, along with Vitamin E, Vitamin B2 and Zinc help protect cells against oxidative stress; Copper helps protect cellular constituents against oxidative stress. Zinc and Vitamin B2 help maintain healthy skin. AGE MANAGEMENT AOX is recommended for people over 40 years of age, cumulatively affected by cell damage.
Incorporarea amestecului de substanțe bioactive în sisteme vegetale de administrare orală cu protecție gastrică (capsule vegetale enterosolubile) asigură biodisponibilitatea optimă a principiilor active gastro-sensibile dar si protecția mucoasei gastrice față de aciditatea componentelor (acidul alfa Iipoic, acidul ascorbic).The incorporation of the mixture of bioactive substances in herbal systems of oral administration with gastric protection (enteric soluble vegetable capsules) ensures the optimal bioavailability of gastro-sensitive active principles but also the protection of the gastric mucosa against the acidity of components (alpha Iipoic acid, ascorbic acid).
Se prezintă modalitatea de realizare a formuleiThe way of making the formula is presented
Exemplul 1. Compoziția pentru 403 mg produs ce poate fi inclus într-o formă de administrare orală (capsulă) este L-carnitină-110mg; extract din frunze de Ceai-verde (Camellia sinensis), standardizat ia 50% polifenoli-75mg; Vitamina C/acid ascorbic-40mg; Lcarnozină-40mg; extract hidroetanolic 25:1 din rădăcină de Turmeric (Curcuma longa), standardizat ia 95% curcuminoide-40mg; acid alfa lipoic-32,75mg; extract din alge marine (Haematococcus pluvialis), cu 2,5% astaxantină-15mg; extract din rădăcină de Polygonum Cuspidatum, cu 50% resveratroi-12,5mg; extract din scoarță de Pin-maritim (Pinus pinaster), standardizat ia 99% picnogenol-12,5mg; coenzima Q10-10mg; agenți antiaglomeranți: stearat de magneziu, dioxid de siliciu coloidai; vitamina E/dl-alfa acetat de tocoferol 50% (maltodextrină, amidon modificat, dioxid de siliciu)-3mg; oxid de zinc-1,56mg; PQQ/pirolochinolină chinonă-1,25mg: bisglicinat de cupru-0,43mg; vitamina B2/riboflavina0,18mg.Example 1. The composition for 403 mg product that can be included in an oral form (capsule) is L-carnitine-110 mg; Green Tea (Camellia sinensis) leaf extract, standardized at 50% polyphenols-75mg; Vitamin C / ascorbic acid-40mg; Lcarnosine-40mg; 25: 1 hydroethanolic extract from Turmeric (Curcuma longa) root, standardized to 95% curcuminoids-40mg; alpha lipoic acid-32.75mg; seaweed extract (Haematococcus pluvialis), with 2.5% astaxanthin-15mg; Polygonum Cuspidatum root extract, with 50% resveratroi-12.5mg; Pine bark extract (Pinus pinaster), standardized takes 99% pycnogenol-12.5mg; coenzyme Q10-10mg; anti-caking agents: magnesium stearate, colloidal silicon dioxide; vitamin E / dl-alpha tocopherol acetate 50% (maltodextrin, modified starch, silicon dioxide) -3mg; zinc oxide-1.56mg; PQQ / quinone pyrroloquinoline-1.25 mg: copper bisglycinate-0.43 mg; vitamin B2 / riboflavin0.18mg.
Materiile prime se identifică, se dozează principiile active. Se cântăresc și se adaugă in vasul de preparare în ordinea descrescătoare a masei. Amestecul se omogenizează în mediu anhidru și se plasează în forma de adinistrare orală capsule gelatinoase tari.The raw materials are identified, the active principles are dosed. Weigh and add to the cooking vessel in descending order of mass. The mixture is homogenized in anhydrous medium and placed in the form of oral administration of hard gelatin capsules.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Exemplul 2. Se procedează ca ia exemplul 1. Compoziția pentru 403 mg produs ce poate fi inclus într-o formă de administrare orală (capsulă) este L-carnitină-1 10mg; extract din frunze de Ceai-verde (Camellia sinensis), standardizat la 50% polifenoli-75mg; Vitamina C/acid ascorbic-40mg; L-carnozină-40mg; extract hidroetanolic 25:1 din rădăcină de Turmeric (Curcuma longa), standardizat la 95% curcuminoide-40mg; acid alfa lipoic-32,75mg; extract din alge marine (Haematococcus pluvialis), cu 2,5% astaxantină-15mg: extract din rădăcină de Poiygonum Cuspidatum, cu 50% resveratroi-12,5mg; extract din scoarță de Pin-maritim (Pinus pinaster), standardizat la 99% picnogenol-12,5mg, coenzima Q10-10mg; agenți antiaglomeranți: stearat de magneziu, dioxid de siliciu coloidal; vitamina E/dl-aifa acetat de tocoferol 50% (maltodextrină, amidon modificat, dioxid de siliciu)-3mg; oxid de zinc-1,56mg; PQQ/pirolochinolină chinonă-1,25mg; bisglicinat de cupru-0,43mg; vitamina B2/riboflavina0,18mg.Example 2. Proceed as in Example 1. The composition for the 403 mg product which may be included in an oral form (capsule) is L-carnitine-1 10 mg; Green Tea (Camellia sinensis) leaf extract, standardized at 50% polyphenols-75mg; Vitamin C / ascorbic acid-40mg; L-carnosine-40mg; 25: 1 hydroethanolic extract from Turmeric (Curcuma longa) root, standardized at 95% curcuminoids-40mg; alpha lipoic acid-32.75mg; seaweed extract (Haematococcus pluvialis), with 2.5% astaxanthin-15mg: Poiygonum Cuspidatum root extract, with 50% resveratroi-12.5mg; Pine bark extract (Pinus pinaster), standardized at 99% pycnogenol-12.5mg, coenzyme Q10-10mg; anti-caking agents: magnesium stearate, colloidal silicon dioxide; vitamin E / dl-aifa tocopherol acetate 50% (maltodextrin, modified starch, silicon dioxide) -3mg; zinc oxide-1.56mg; PQQ / quinone pyrroloquinoline-1.25 mg; copper bisglycinate-0.43mg; vitamin B2 / riboflavin0.18mg.
Materiile prime se identifică, se dozează principiile active. Se cântăresc și se adaugă in vasul de preparare în ordinea descrescătoare a masei. Amestecul se omogenizează în mediu anhidru și se plasează în forma de adinistrare orală pentru comprimare.The raw materials are identified, the active principles are dosed. Weigh and add to the cooking vessel in descending order of mass. The mixture is homogenized in anhydrous medium and placed in the form of an oral administration for compression.
Etapa 1Stage 1
Materiile prime se recepționează conform prevederilor Specificațiilor tehnice ale producătorului, ale Farmacopeii Europene ediția curentă.The raw materials are received according to the provisions of the Technical Specifications of the manufacturer, of the current edition of the European Pharmacopoeia.
Ambalajele se recepționează calitativ și cantitativ, conform documentației însoțitoare de la producător.The packaging is received qualitatively and quantitatively, according to the accompanying documentation from the manufacturer.
Etapa 2Stage 2
Cântărirea primară și secundară (de control a cântăririi primare) pentru o serie de produs se realizează pe balanțe electronice, în încăpere cu climatizare controlată (temperatură și umiditate constante: 21 ± 2 °C, respectiv 50 % UR ±10 %).The primary and secondary weighing (control of the primary weighing) for a series of products is performed on electronic scales, in a room with controlled air conditioning (constant temperature and humidity: 21 ± 2 ° C, respectively 50% RH ± 10%).
Etapa 3Stage 3
Omogenizarea materiilor prime se realizează în utilajul Roto P, în sistem închis.The homogenization of the raw materials is performed in the Roto P machine, in a closed system.
în această etapă controlul interfazic determină pierderea prin uscare a amestecului, pe o probă de 5 g. Se determină randamentul practic al etapei de omogenizare, care trebuie să fie de minim 98 %.In this step, the interphase control determines the loss by drying of the mixture, on a sample of 5 g. The practical yield of the homogenization step, which must be at least 98%, is determined.
Amestecul omogen, ca produs intermediar, se descarcă în container din oțel inoxidabil, etichetat corespunzător și este analizat de către Laboratorul de control al calității, conform prevederilor S.T. și, numai după obținerea buletinului de analiză, care atestă conformitatea, se poate trece la etapa următoare, de încapsulare.The homogeneous mixture, as an intermediate product, is discharged into a properly labeled stainless steel container and analyzed by the Quality Control Laboratory in accordance with the provisions of S.T. and, only after obtaining the analysis bulletin, which certifies the conformity, it is possible to proceed to the next stage, encapsulation.
Etapa 4Step 4
Umplerea capsulelor cu amestecul omogen de ingrediente active și excipienti se realizează cu o mașina rotativă de tip ZANASI 40E (mașina rotativa de încapsulat).The filling of the capsules with the homogeneous mixture of active ingredients and excipients is performed with a rotary machine of ZANASI 40E type (rotary encapsulation machine).
a 2020 00173and 2020 00173
01/04/202001/04/2020
Controlul interfazic verifică masa medie pe capsulă, uniformitatea masei conținutului 462 capsulei.The interphase control checks the average mass per capsule, the uniformity of the mass of the contents of the 462 capsule.
Randamentul etapei de umplere a capsulelor este de minimum 37 %.The yield of the capsule filling stage is at least 37%.
464 Capsulele, ca produs intermediar - vrac, se descarcă în containere din oțel inoxidabil, etichetate corespunzător și sunt analizate de către Laboratorul de Control al Calității.464 The capsules, as intermediate - bulk, are unloaded into stainless steel containers, appropriately labeled and analyzed by the Quality Control Laboratory.
466 După eliberarea buletinului de analiză, care atestă conformitatea produsului, se poate trece la etapa următoare, cea de ambalare.466 After the issuance of the analysis bulletin, which certifies the conformity of the product, it is possible to proceed to the next stage, that of packaging.
a 2020 00173and 2020 00173
01/04/202001/04/2020
468468
Testarea produsului conform invențieiTesting of the product according to the invention
470 Determinarea parametrilor fizico-chimici ai produsului preparat470 Determination of physico-chemical parameters of the prepared product
Tabel nr. I Caracteristicile produsului preparatTable no. I Characteristics of the prepared product
Aspectul - capsulele sunt inspectate vizual în ceea ce privește aspectul, culoarea și forma 474 pe un număr reprezentativ de capsule.Appearance - the capsules are visually inspected for appearance, color and shape 474 on a representative number of capsules.
Mirosul și gustul sunt parametrii determinați prin metoda organoleptică.Smell and taste are the parameters determined by the organoleptic method.
476 Parametrii masă medie și uniformitatea masei se determină conform prevederilor din Farmacopeea Europeană în vigoare.476 The parameters of average mass and uniformity of mass are determined according to the provisions of the European Pharmacopoeia in force.
478 Timpul de dezagregare se determină prin metoda A prevăzută în Farmacopeea Europeană în vigoare.478 The disaggregation time is determined by method A provided in the European Pharmacopoeia in force.
480 Conținutul în apă - se determină prin titrare cu reactivul Karl Fischer, metoda de lucru fiind cea prevăzută în Farmacopeea Europeană.480 Water content - is determined by titration with Karl Fischer reagent, the working method being that provided in the European Pharmacopoeia.
482 Control microbiologic - determinarea contaminării microbiene pentru numărul total de bacterii, fungi și Escherichia coli se efectuează conform 2.6.12 și 2.6.13 - FE categoria 3A 484 din Farmacopoeea Europeană în vigoare.482 Microbiological control - determination of microbial contamination for the total number of bacteria, fungi and Escherichia coli is carried out according to 2.6.12 and 2.6.13 - FE category 3A 484 of the European Pharmacopoeia in force.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Determinarea conținutului total in polifenoli in formula inovativa AOXDetermination of the total polyphenol content in the innovative formula AOX
Caracterizarea spectrofotometrică și determinarea conținutului total de polifenoli din formula inovativa prin metoda colorimetrică Folin-Ciocalteu este utilizată pentru determinarea conținutului total de polifenoli din compuși ce conțin extracte vegetale.Spectrophotometric characterization and determination of the total polyphenol content of the innovative formula by the Folin-Ciocalteu colorimetric method is used to determine the total polyphenol content of compounds containing plant extracts.
Material si metodaMaterial and method
Principiul metodeiThe principle of the method
Reactivul Folin-Ciocalteu conține acizi fosfo-tungstici ca și oxidanți, care la reducerea cu grupările hidroxi fenolice ușor oxidate produc o culoare albastră cu o absorbție maximă la 765 nm prin formarea albăstruiul de tungsten și molibden. Reactivul Folin-Ciocalteu reacționează cu o gamă largă de compuși polifenolici; deși răspunsul poate varia cu componentele individuale, selectarea acidului clorogenic ca standard de calibrare permite obținerea de date utile cu privire ia poiifenolii totali. In prezentul studiu am determinat prin metoda Folin-Ciocalteu conținutul total de polifenol (Total Polyphenol Content = TPC) prin stabilirea conținutului în echivalenți acid clorogenic [291.Folin-Ciocalteu reagent contains phospho-tungsten acids as oxidants, which when reduced with slightly oxidized hydroxy phenolic groups produce a blue color with a maximum absorption at 765 nm by the formation of tungsten and molybdenum blue. Folin-Ciocalteu reagent reacts with a wide range of polyphenolic compounds; although the response may vary with the individual components, the selection of chlorogenic acid as a calibration standard allows useful data to be obtained on total polyphenols. In the present study we determined by the Folin-Ciocalteu method the total polyphenol content (Total Polyphenol Content = TPC) by establishing the content in chlorogenic acid equivalents [291.
ReactiviReagents
Apă distilată, Amestec de extracție: Alcool etilic i apă distilată (75: 25 % v/v). Preparare amestec de extracție: se măsoară 750 ml de alcool etilic într-un balon, peste care se adaugă 250ml apă distilată și se omogenizează. Soluție Reactiv Folin-Ciocalteu 10%. Preparare soluție Reactiv Folin-Ciocalteu 10% : se pipetează 10ml Reactiv Folin-Ciocalteu într-un balon cotat de 100ml, se aduce la cota cu apă distilată și se omogenizează (Observație: soluția Reactiv Folin-Ciocalteu 10%, se prepară zilnic). Soluție de carbonat de sodiu 7,5% Preparare soluție carbonat de sodiu 7,5%: se cântăresc la balanța analitică 7,5 g de carbonat de sodiu anhidru (Na2CO3) și se introduc într-un balon cotat de 100ml, se adaugă 70 ml apă distilată și se agită până la dizolvarea completă; apoi se aduce la cotă cu același solvent. - Soluții standard de acid clorogenic Preparare Soluții standard de acid clorogenic:Soluție stoc: se cântăresc la balanța analitică 5mg acid clorogenic se dizolvă în apă distilată și se aduce la cotă, într-un balon cotat de 5ml. Din Soluția stoc conform Tabelului nr.1, se fac diluții la baloane cotate de 10 ml, cu apă distilată și se omogenizează.Distilled water, Extraction mixture: Ethyl alcohol and distilled water (75: 25% v / v). Preparation of extraction mixture: measure 750 ml of ethyl alcohol in a flask, over which 250 ml of distilled water are added and mix. Folin-Ciocalteu Reagent Solution 10%. Preparation of 10% Folin-Ciocalteu Reagent solution: pipette 10 ml of Folin-Ciocalteu Reagent in a 100 ml volumetric flask, make up to volume with distilled water and mix (Note: 10% Folin-Ciocalteu Reagent solution, prepare daily). Sodium carbonate solution 7,5% Preparation of sodium carbonate solution 7,5%: weigh 7,5 g of anhydrous sodium carbonate (Na2CO3) into the analytical balance and place in a 100 ml graduated flask, add 70 ml of distilled water and stir until completely dissolved; then it is leveled with the same solvent. - Standard solutions of chlorogenic acid Preparation Standard solutions of chlorogenic acid: Stock solution: weigh to the analytical balance 5mg chlorogenic acid is dissolved in distilled water and brought to the level in a 5ml volumetric flask. From the stock solution according to Table no. 1, dilutions are made in 10 ml volumetric flasks with distilled water and homogenized.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Tabel nr. II - Soluții standard diluate cu acid clorogenicTable no. II - Standard solutions diluted with chlorogenic acid
Aparatura - Balanța analitică, precizie de ± 0,001 g; - Baie de apă, pentru a menținute temperatura la 70 ° C ± 1 ° C; - Mixer Vortex, pentru amestecare eficientă în timpul extracției. - Centrifugă, capabilă sa realizeze 4000 r I min, dar de această dată se utilizează 2500r/min; - Spectrofotometru UV/ VIS, (Jasco-V-530); - Pipete din sticlă clasa A, pentru a acoperi intervalul de volum pentru diluții standard și extracte;Equipment - Analytical balance, accuracy of ± 0.001 g; - Water bath, to maintain the temperature at 70 ° C ± 1 ° C; - Vortex mixer, for efficient mixing during extraction. - Centrifuge, capable of achieving 4000 r I min, but this time 2500 r / min is used; - UV / VIS spectrophotometer, (Jasco-V-530); - Class A glass pipettes, to cover the volume range for standard dilutions and extracts;
- Flacoane volumetrice clasă A, cu capacități de 5, 10 și 100 ml; - Tuburi de extracție, sticlă, cu o capacitate de 10 ml, capabile să reziste la centrifugare.- Class A volumetric flasks with a capacity of 5, 10 and 100 ml; - Extraction tubes, glass, with a capacity of 10 ml, capable of withstanding centrifugation.
Probe luate in lucruTests taken in progress
S-a luat în lucru pulberea conținută de capsulele produsului movativ AOX care a fost a fost omogenizată, pentru a obține un eșantion reprezentativ.The powder contained in the capsules of the AOX movable product which was homogenized was taken to obtain a representative sample.
Extracția polifenolilorExtraction of polyphenols
Din pulberea de AOX s-au pregătit pentru extracția polifenolilor câte doua probe, astfel: 0,200 g de probă de testat într-un tub de extracție, peste care se adaugă 5 ml amestec etanolic de extracție și se menține pe baia pe apă 5 minute la 700°C; se agita la Vortex 10 minute pentru a se dizolva proba și se lasă sâ se răcească la temperatura camerei; este centrifugat timp de 10 minute ia 2500 rpm; supernatantul este colectat cu o pipetă din tubul de extracție, iar extracția se reia cu încă 5 ml amestec de extracție; filtratele se reunesc întrun balon de 10 ml cu același solvent și se omogenizează.From the AOX powder, two samples were prepared for the extraction of polyphenols, as follows: 0.200 g of test sample in an extraction tube, over which 5 ml of ethanolic extraction mixture is added and kept in the water bath for 5 minutes at 700 ° C; shake with Vortex for 10 minutes to dissolve the sample and allow to cool to room temperature; is centrifuged for 10 minutes at 2500 rpm; the supernatant is collected with a pipette from the extraction tube and the extraction is resumed with another 5 ml of extraction mixture; the filtrates are combined in a 10 ml flask with the same solvent and mixed.
RezultateResults
Din fiecare soluție standard de acid clorogenic se pipetează câte 1 ml în baloane cotate de 10 mi, apoi se adaugă în fiecare balon câte 5 ml Reactiv Folin-Ciocalteu 10%, 4 ml soluție de carbonat de sodiu 7,5% și se aduce la cotă cu apă distilată.From each standard solution of chlorogenic acid, pipette 1 ml into 10 ml graduated flasks, then add to each flask 5 ml of 10% Folin-Ciocalteu Reagent, 4 ml of 7.5% sodium carbonate solution and make up to quota with distilled water.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Soluțiile astfel preparate, se mențin la temperatura camerei 60 minute, apoi se citesc absorbantele la Spectrofotometru UV/ VIS, (Jasco-V-530) la lungimile de undă de 765 ± 2 nm, în cuve de cuarț de 1cm, față de apă distilată, ca lichid de compensare.The solutions thus prepared are kept at room temperature for 60 minutes, then the absorbents are read on a UV / VIS Spectrophotometer (Jasco-V-530) at wavelengths of 765 ± 2 nm, in 1 cm quartz vats, with distilled water. , as compensating liquid.
Curba de calibrareCalibration curve
Domeniul testat ai concentrației în acid clorogenic este 0-100 pg/ml, iar curba de calibrare obținută este prezentată în figura nr. 1:The tested range of chlorogenic acid concentration is 0-100 pg / ml, and the calibration curve obtained is presented in figure no. 1:
Curba de calibrare - acid clorogenicCalibration curve - chlorogenic acid
Figura 9 Curba de calibrare acid clorogenicFigure 9 Chlorogenic acid calibration curve
Standardul trebuie să aibă o absorbanță mai mică de 0,8. De asemenea, este important ca proba să se afle în domeniul curbei de calibrare. în cazul în care proba prezintă o absorbanță mai mare decât a standardului G, testul se repetă modificând diluția.The standard must have an absorbance of less than 0.8. It is also important that the sample is in the range of the calibration curve. if the sample has an absorbance higher than the G standard, the test is repeated by changing the dilution.
Determinarea conținutului total de polifenoiiDetermination of the total polyphenol content
Conținutul a fost exprimat ca echivalenți ai acidului clorogenic (chlogenic acid equivalents = CAE) folosind acid clorogenic (0-100 pg/mL, R2 = 0,9976) curba standard.The content was expressed as chlogenic acid equivalents (CAE) using chlorogenic acid (0-100 pg / mL, R2 = 0.9976) standard curve.
Fiecare extract din probă a fost diluat cu apă la raport 1: 100 și apoi s-au făcut mai multe diluții, astfel 1: 10, 2: 10; 2,5: 10 și 5: 10. Din fiecare soluție probă s-a p.petat câte 1ml în baloane cotate de 10ml, apoi s-a adaugat în fiecare balon câte 5ml Reactiv Folin-Ciocalteu 10%, 4 ml soluție de carbonat de sodiu 7,5% adus la cotă cu apă distilată.Each extract from the sample was diluted with water in a ratio of 1: 100 and then several dilutions were made, thus 1:10, 2:10; 2,5:10 and 5:10. From each sample solution, 1 ml was applied in 10 ml volumetric flasks, then 5 ml of 10% Folin-Ciocalteu Reagent, 4 ml of sodium carbonate solution 7 was added to each flask. 5% quoted with distilled water.
Soluțiile preparate au fost menținute la temperatura camerei 60 minute, apoi au fost citite absorbantele la Spectrofotometru UV/ VIS, (Jasco-V-530) la lungimile de undă de 765 ± 2 nm, în cuve de cuarț de 1cm, față de apă distilată, ca lichid de compensare.The prepared solutions were kept at room temperature for 60 minutes, then the absorbents were read on a UV / VIS Spectrophotometer (Jasco-V-530) at wavelengths of 765 ± 2 nm, in 1 cm quartz vats, with distilled water. , as compensating liquid.
a 2020 00173and 2020 00173
01/04/202001/04/2020
Tabel nr. III - Soluții standard diluate din proba produsului inovativ AOXTable no. III - Diluted standard solutions from the sample of the innovative product AOX
<68<68
570570
572572
574574
Am testat două probe din produsul ,AOX, din care s-au făcut mai multe diluții în limitele domeniului studiat pe curba de caiibrare, din figura nr. 1. Concentrația în polifenoli din probe a fost derivată de la curba standard a acidului clorogenic cuprins între 0 și 100 pg/mL (R2 = 0,9376). Concentrația totală de polifenol în extractele originale (TPCo) s-a exprimat sub formă de pg CAE/mg probă, in urma interpretării probelor se constată că acestea sunt omogene, iar rezultatele se încadrează în domeniul 31,56 38,57 pg CAE/mg probă.We tested two samples of the product, AOX, from which several dilutions were made within the limits of the field studied on the calibration curve, from figure no. 1. The concentration of polyphenols in the samples was derived from the standard chlorogenic acid curve between 0 and 100 pg / mL (R 2 = 0.9376). The total concentration of polyphenols in the original extracts (TPCo) was expressed as pg CAE / mg sample, following the interpretation of the samples it is found that they are homogeneous, and the results fall in the range of 31.56 38.57 pg CAE / mg sample.
Concluziiconclusions
576 Produsul testat conține peste 30 micrograme echivalenți acid clorogenic (CAb) pentru un miligram, respectiv peste 3 mg echivalenți acid ciorogenic/100 mg probă (3%CAE).576 The product tested contains more than 30 micrograms chlorogenic acid equivalents (CAb) per milligram and 3 mg equivalents ciorogenic acid / 100 mg sample (3% CAE).
578578
580 582580 582
584 a 2020 00173584 and 2020 00173
01/04/202001/04/2020
REFERINȚE SELECTIVESELECTIVE REFERENCES
740 STUDII CLINICE740 CLINICAL STUDIES
742 Resveratrol, un antioxidant natural, are un efect de protecție asupra leziunilor hepatice provocate de expunerea la arsenic anorganic. Zhigang Zhang, Li Gao, Yanyan Cheng, Jing 744 Jiang, Yan Chen, Huijie Jiang, Hongxiang Yu, Anshan Shan, Baojing Cheng742 Resveratrol, a natural antioxidant, has a protective effect on liver damage caused by inorganic arsenic exposure. Zhigang Zhang, Li Gao, Yanyan Cheng, Jing 744 Jiang, Yan Chen, Huijie Jiang, Hongxiang Yu, Anshan Shan, Baojing Cheng
746 Abstract746 Abstract
Resveratrol (Rev) poate ameliora toxicitatea citotoxică indusă de chimioterapie și stresul 748 oxidativ. Trioxidul de arsen (As2O3) este o substanță citotoxică cunoscută și un agent chimioterapeutic puternic. Cu toate acestea, mecanismele prin care resveratrolul protejează 750 ficatul împotriva efectelor citotoxice ale As2O3 nu sunt cunoscute. Prin urmare, în studiul de față am investigat mecanismele implicate în acțiunea resveratrolului folosind un model de /52 pisică în care hepatotoxicitatea a fost indusă prin tratamentul cu As2O3. Am constatat că pretratamentul cu resveratrol, administrat utilizând un regim de doză comparabil din punct de 754 vedere clinic, a inversat modificările parametrilor monologici și ai ficatului induși de As2O3 și a dus la o îmbunătățire semnificativă a funcției hepatice. Tratamentul cu resveratrol a 756 îmbunătățit, de asemenea, activitățile enzimelor antioxidante și a atenuat creșterile induse de As2O3 în speciile reactive de oxigen și producția de malondialdehidă.Resveratrol (Rev) may ameliorate chemotherapy-induced cytotoxic toxicity and oxidative stress. Arsenic trioxide (As 2 O 3 ) is a known cytotoxic substance and a potent chemotherapeutic agent. However, the mechanisms by which resveratrol protects the liver against the cytotoxic effects of As 2 O 3 are unknown. Therefore, in the present study we investigated the mechanisms involved in the action of resveratrol using a / 52 cat model in which hepatotoxicity was induced by As 2 O 3 treatment . We found that pre-treatment with resveratrol, administered using a clinically comparable dose regimen, reversed changes in monologue and liver parameters induced by As 2 O 3 and led to a significant improvement in liver function. Resveratrol treatment 756 also improved the activities of antioxidant enzymes and attenuated As 2 O 3- induced increases in reactive oxygen species and malondialdehyde production.
758 în plus, resveratrolul a atenuat reducerea indusă de As2O3 în raportul dintre glutationul redus și glutationul oxidat și reținerea arsenicului în țesutul hepatic.In addition, resveratrol attenuated the reduction induced by As 2 O 3 in the ratio of reduced glutathione to oxidized glutathione and the retention of arsenic in liver tissue.
760 Aceste descoperiri oferă o mai bună înțelegere a mecanismelor prin care resveratrolul modulează modificările induse de As2O3 în funcția hepatică și în morfologia țesuturilor. Ele 762 oferă de asemenea o rațiune mai puternică pentru utilizarea clinică a resveratrolului pentru reducerea hepatotoxicității induse de As2O3.760 These findings provide a better understanding of the mechanisms by which resveratrol modulates As 2 O 3- induced changes in liver function and tissue morphology. They 762 also provide a stronger rationale for the clinical use of resveratrol to reduce As 2 O 3- induced hepatotoxicity.
764764
Potențialul hepatoprotector și antioxidant al Pycnogenol® în hepatotoxicitatea indusă de 766 acetaminofen ia șobolani. Raskovic A, Bukumirovic N, Paut Kusturica M, Milic N, Cabarkapa V, Borisev I, Capo I, Miljkovic D, Stilinovic N, Mikov M.The hepatoprotective and antioxidant potential of Pycnogenol® in hepatotoxicity induced by 766 acetaminophen in rats. Raskovic A, Bukumirovic N, Paut Kusturica M, Milic N, Cabarkapa V, Borisev I, Capo I, Miljkovic D, Stilinovic N, Mikov M.
768768
AbstractAbstract
770 Pycnogenol® (PYC) este deja utilizat ca supliment alimentar și medicament pe bază de plante datorită proprietăților sale puternic antioxidante. Scopul studiului a fost de a examina 772 efectul protector al PYC asupra leziunilor hepatice acute induse de acetaminofen la șobolani. Efectul PYC asupra hepatotoxicității induse de acetaminofen la șobolani a fost 774 examinat prin determinarea parametrilor biochimici, activitatea antioxidantă in vitro, evaluarea histologică și starea oxidativă în omogenatele hepatice. Cele mai bune proprietăți a 2020 00173770 Pycnogenol® (PYC) is already used as a food supplement and herbal medicine due to its strong antioxidant properties. The aim of the study was to examine the protective effect of PYC on acute liver damage induced by acetaminophen in rats. The effect of PYC on acetaminophen-induced hepatotoxicity in rats was 774 examined by determining biochemical parameters, in vitro antioxidant activity, histological evaluation and oxidative status in liver homogenates. The best properties of 2020 00173
01/04/202001/04/2020
776 antioxidante au fost demonstrate în extractele metanolice. Pre-tratamentui de șapte zile cu PYC a suprimat expresia proteine! CYP2E1 indusă de administrarea unei doze toxice de776 antioxidants have been demonstrated in methanolic extracts. Seven days of pre-treatment with PYC suppressed protein expression! CYP2E1 induced by the administration of a toxic dose of
778 acetaminofen. PYC la 50 mg/kg a arătat capacitatea de a scădea semnificativ nivelul de malondialdehidă (MDA), comparativ cu grupul în care s-a administrat acetaminofen.778 acetaminophen. PYC at 50 mg / kg showed the ability to significantly decrease malondialdehyde (MDA) levels compared to the group in which acetaminophen was administered.
780 Activitatea enzimatică a xantin oxidazei (XOD) a fost semnificativ crescută în grupul tratat cu acetaminofen comparativ cu grupul de control, în timp ce administrarea concomitentă de 782 PYC într-o doză de 50 mg/kg a redus semnificativ activitatea acestei enzime. Scăderea semnificativă a conținutului hepatic a glutationului (GSH) la șobolanii intoxicați cu 784 acetaminofen comparativ cu șobolanii martor a fost îmbunătățită prin administrarea concomitentă de PYC la 50 mg/kg. Efectul de protecție al PYC asupra leziunii hepatice 786 acute induse de acetaminofen la șobolani a arătat cei mai bun potențial antioxidant in vitro exprimat în extractul metanolic și evaluarea histoiogică consecutivă și starea oxidativă în 788 omogenatele hepatice.780 The enzymatic activity of xanthine oxidase (XOD) was significantly increased in the acetaminophen-treated group compared to the control group, while co-administration of 782 PYC at a dose of 50 mg / kg significantly reduced the activity of this enzyme. The significant decrease in hepatic glutathione (GSH) content in rats intoxicated with 784 acetaminophen compared to control rats was improved by concomitant administration of PYC to 50 mg / kg. The protective effect of PYC on acetaminophen-induced acute liver injury 786 in rats showed the best in vitro antioxidant potential expressed in methanolic extract and the consequent histological assessment and oxidative status in 7 88 liver homogenates.
a 2020 00173and 2020 00173
01/04/202001/04/2020
BIBLIOGRAFIEBIBLIOGRAPHY
Rodriguez-Enriquez S, Pacheco-Velăzquez SC, Marin-Hernăndez Â, Gaiiardo-Perez JC, RobledoCadena DX, Hernăndez-Resendiz I, Garcia-Garcia JD, Beimont-Diaz J, Lopez-Marure R, HernăndezEsquivel L, Sănchez-Thomas R, Moreno-Sănchez R. - Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress. Toxicol Appl Pharmacoi. 2019 Mar 13. pii: S0041-008X( 19)30090-0.Rodriguez-Enriquez S, Pacheco-Velăzquez SC, Marin-Hernăndez Â, Gaiiardo-Perez JC, RobledoCadena DX, Hernăndez-Resendiz I, Garcia-Garcia JD, Beimont-Diaz J, Lopez-Marure R, HernăndezEsquivel L, Sănchez-Thomas R , Moreno-Sănchez R. - Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress. Toxicol Appl Pharmacoi. 2019 Mar 13. pii: S0041-008X (19) 30090-0.
2. Z. Zhang, L. Gao, Y. Cheng, J. Jiang, Y. Chen, H. Jiang, H. Yu, A. Shan and B. Cheng - Resveratrol, a Natural Antioxidant, Has a Proiective Effect on Liver Injury Induced by Inorganic Arsenic Exposure Biomed Res Int. 2014; 2014: 617202.2. Z. Zhang, L. Gao, Y. Cheng, J. Jiang, Y. Chen, H. Jiang, H. Yu, A. Shan and B. Cheng - Resveratrol, a Natural Antioxidant, Has a Proiective Effect on Liver Injury Induced by Inorganic Arsenic Exposure Biomed Res Int. 2014; 2014: 617202.
3. Lehninger AL (1970) : Biochemistry, Worth Publisher inc. 19703. Lehninger AL (1970): Biochemistry, Worth Publisher inc. 1970
4. Sauberlich HE (1987) : Nutrițional Aspects of Pyridine Nucieotides, in Dolphin D, Poulson r, Avramovic O (editors) : Pyridine Nucieotide Coenzymes (Part B), John Wiley & Sons, Inc. 1987, pp. 599-626.4. Sauberlich HE (1987): Nutritional Aspects of Pyridine Nucieotides, in Dolphin D, Poulson r, Avramovic O (editors): Pyridine Nucieotide Coenzymes (Part B), John Wiley & Sons, Inc. 1987, pp. 599-626.
5. A!berts B, et al (1983): Molecular Biology of the Cell, Garland Publishing, 1983, pp. 491-4955. A! Berts B, et al (1983): Molecular Biology of the Cell, Garland Publishing, 1983, pp. 491-495
6. Catherine C. Neto, Joe A. Vinson (2011) Herbal Medicine: Biomolecular and Clinica! Aspects. 2nd edition, Chapter6.1. Cranberry. introduction and tradițional origins6. Catherine C. Neto, Joe A. Vinson (2011) Herbal Medicine: Biomolecular and Clinical! Aspects. 2nd edition, Chapter6.1. Cranberry. introduction and traditional origins
7. Sebastian J. Padayatty, Arie Katz, Yaohui Wang, Peter Eck, Oran Kwon, Je-Hyuk Lee, Shenglin Chen, Christopher Corpe, Anand Dutta, Sudhir K Dutta, Mark Levine (2003) Vitamin C as an Antioxidant: Evaiuation of Its Role in Disease Prevention. Volume 22, issue 1, 18-357. Sebastian J. Padayatty, Arie Katz, Yaohui Wang, Peter Eck, Oran Kwon, Je-Hyuk Lee, Shenglin Chen, Christopher Corpe, Anand Dutta, Sudhir K Dutta, Mark Levine (2003) Vitamin C as an Antioxidant: Evaiuation of Its Role in Disease Prevention. Volume 22, issue 1, 18-35
8. European Food Safety Authority, Scientific Committee on Food. Toierable Upper Intake Levels for Vitamins and Minerals. 2006: ISBN: 92-9199-014-08. European Food Safety Authority, Scientific Committee on Food. Toierable Upper Intake Levels for Vitamins and Minerals. 2006: ISBN: 92-9199-014-0
9. Spencer H, Norris C, Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man J Am Goii Nutr. 1994; 13(5):479-484.9. Spencer H, Norris C, Williams D. Inhibitory effects of zinc on magnesium balance and magnesium absorption in man J Am Goii Nutr. 1994; 13 (5): 479-484.
10. Shiis ME. Magnesium In: O'Deli BL, Sunde RA, eds. Handbook of nutritionally essentiai minerals. New York: Marcel Dekker, inc: 1997:1 17-152.10. Shiis ME. Magnesium In: O'Deli BL, Sunde RA, eds. Handbook of nutritionally essentiai minerals. New York: Marcel Dekker, inc: 1997: 1 17-152.
11. Raskovic A, Bukumirovic N, Paut Kusturica M, MiliC N, Cabarkapa V, Borisev I, Capo I, Miljkovic D, Stiiinovic N, Mikov M. Hepatoprotective and antioxidant potențial of Pycnogenol® in acetaminophen-induced hepatotoxicity in rats. Phytother Res. 2019 Mar;33(3):631 -63911. Raskovic A, Bukumirovic N, Paut Kusturica M, MiliC N, Cabarkapa V, Borisev I, Capo I, Miljkovic D, Stiiinovic N, Mikov M. Hepatoprotective and potential antioxidant of Pycnogenol® in acetaminophen-induced hepatotoxicity in rats. Phytother Res. 2019 Mar; 33 (3): 631 -639
12. Ikemoto K, Mori S, Mukai K. Synthesis and crystai structure of pyrroloquinoline quinol (PQQH2) and pyrroloquinoline quinone (PQQ). Acta Crystallogr B Struct Sci Cryst Eng Mater. 2017 Jun 1 ;73(Pt 3):489-49712. Ikemoto K, Mori S, Mukai K. Synthesis and crystai structure of pyrroloquinoline quinol (PQQH 2 ) and pyrroloquinoline quinone (PQQ). Acta Crystallogr B Struct Sci Cryst Eng Mater. 2017 Jun 1; 73 (Pt 3): 489-497
13. Ghosh D1, Brewer GJ2. Externai cys/cySS redox state modification controis the intracellular redox state and neurodegeneration via Akt in aging and Aizheimer's disease mouse model neurons. J Alzheimers Dis. 2014,42(1):313-24. doi: 10.3233/JAD-132756.13. Ghosh D 1 , Brewer GJ 2 . Externai cys / cySS redox state modification controis the intracellular redox state and neurodegeneration via Akt in aging and Aizheimer's disease mouse model neurons. J Alzheimers Dis. 2014,42 (1): 313-24. doi: 10.3233 / JAD-132756.
Ghosh D1, Levault KR, Brewer GJ. Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons. Aging Ceil. 2014 Aug;13(4):631-40. doh 10.1111/acel.12216. Epub 2014 Mar 21.Ghosh D 1 , Levault KR, Brewer GJ. Relative importance of redox buffers GSH and NAD (P) H in age-related neurodegeneration and Alzheimer’s disease-like mouse neurons. Aging Ceil. 2014 Aug; 13 (4): 631-40. doh 10.1111 / acel.12216. Epub 2014 Mar 21.
15. Pop, A. Pop, C, Terapii mitocondriale celulare. Coenzima E1, (2015) Maramureșul Medical, Numărul 5915. Pop, A. Pop, C, Cellular mitochondrial therapies. Coenzyme E1, (2015) Maramureș Medical, Number 59
16. Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D. Abete, P. (2018). Oxidative stress, aging, and diseases. Clinica! interventions in aging, 13, 757-772. doi:10.2147/CIA.S158513 17. Poulsen, Malene W.; Hedegaard, Rikke V.; Andersen, Jeanette M.; de Courten, Barbora; Bîigel, Susanne: Nieisen, John: Skibsted, Leif H.; Dragsted, Lars O. (October 2013). Advanced giycation endproducts in food and their effects on heaith. Food and Chemical Toxicoiogv. 60' 10-37. doi: 10.1016/j.fct.2O13.06.052. ISSN 1873-6351. PMID 23867544.16. Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D. Abete, P. (2018). Oxidative stress, aging, and diseases. Clinic! interventions in aging, 13, 757-772. doi: 10.2147 / CIA.S158513 17. Poulsen, Malene W .; Hedegaard, Rikke V .; Andersen, Jeanette M .; of Courten, Barbora; Bîigel, Susanne: Nieisen, John: Skibsted, Leif H .; Dragsted, Lars O. (October 2013). Advanced giycation endproducts in food and their effects on heaith. Food and Chemical Toxicoiogv. 60 '10-37. doi: 10.1016 / j.fct.2O13.06.052. ISSN 1873-6351. PMID 23867544.
18, Guney Y, et al. Carnosine may reduce lung injury caused by radiation therapy. Med Hypotheses. 2006;66(5):957-9.18, Guney Y, et al. Carnosine may reduce lung injury caused by radiation therapy. Med Hypotheses. 2006; 66 (5): 957-9.
19. Pizzimenti, S , Ciamporcero, E. S., Daga, M., Pettazzoni, P., Arcaro, A., Cetrangolo, G., . . & Barrera, G. (2013). Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Frontiers in physiology, 4, 24219. Pizzimenti, S, Ciamporcero, E. S., Daga, M., Pettazzoni, P., Arcaro, A., Cetrangolo, G.,. . & Barrera, G. (2013). Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Frontiers in physiology, 4, 242
20. Mazloumi Gavgani, F , Smith Arnesen, V., Jacobsen, R. G., Krakstad, C., Hoivik, E. A., & Lewis, A. E (2018). Class i phosphoinositide 3-Kinase PIK3CA/p110α and ΡΙΚ3ΟΒ/ρ110β isoforms in endometnai cancer. International Journal of molecular Sciences, 79(12), 3931.20. Mazloumi Gavgani, F, Smith Arnesen, V., Jacobsen, R. G., Krakstad, C., Hoivik, E. A., & Lewis, A. E (2018). Class i phosphoinositide 3-Kinase PIK3CA / p110α and ΡΙΚ3ΟΒ / ρ110β isoforms in endometnai cancer. International Journal of Molecular Sciences, 79 (12), 3931.
21. Liu, Q., Raina, A. K., Smith, M. A., Sayre, L. M., & Perry, G. (2003). Hydroxynonenal, toxic carbonyls, and Alzheimer disease. Molecular aspects of medicine, 24(4-5), 305-313.21. Liu, Q., Raina, A. K., Smith, M. A., Sayre, L. M., & Perry, G. (2003). Hydroxynonenal, toxic carbonyls, and Alzheimer's disease. Molecular aspects of medicine, 24 (4-5), 305-313.
a 2020 00173and 2020 00173
01/04/202001/04/2020
22. Ames B. N. (2018). Prolonging healthy aging: Longevity vitamins and proteins. Proceedings of the National Academy of Sciences of the United States of America, 115(43), 10836-10844. dor 10.1073/pnas. 180904511522. Ames B. N. (2018). Prolonging healthy aging: Longevity vitamins and proteins. Proceedings of the National Academy of Sciences of the United States of America, 115 (43), 10836-10844. dor 10.1073 / pnas. 1809045115
23. Geng, Q., Gao, H., Yang, R., Guo, K., & Miao, D. (2019). Pyrroloquinolme Quinone Prevents Estrogen Deficiency-lnduced Osteoporosis by Inhibiting Oxidative Stress and Osteocyte Senescence. International Journal of biological Sciences, 15(1), 58-68. doi: 10.7150/ijbs.2578323. Geng, Q., Gao, H., Yang, R., Guo, K., & Miao, D. (2019). Pyrroloquinolme Quinone Prevents Estrogen Deficiency-lnduced Osteoporosis by Inhibiting Oxidative Stress and Osteocyte Senescence. International Journal of Biological Sciences, 15 (1), 58-68. doi: 10.7150 / ijbs.25783
24. Akagawa, M., Nakano, M., & Ikemoto, K. (2016). Recent progress in studies on the health benefits of pyrroloquinolme quinone. Bioscience, biotechnology, and biochemistry, 80(1), 13-22.24. Akagawa, M., Nakano, M., & Ikemoto, K. (2016). Recent progress in studies on the health benefits of pyrroloquinolme quinone. Bioscience, biotechnology, and biochemistry, 80 (1), 13-22.
25. Huang, Y., Miao, D., & Chen, N. (2015). The treatment effects and mechanisms of pyrroioquinoline quinone on defective teeth and mandible in Bmi-1 knockout mice. Zhonghua kou qiang yi xue za zhiChinese Journal of stomatology, 50(8), 496-502.25. Huang, Y., Miao, D., & Chen, N. (2015). The treatment effects and mechanisms of pyrroioquinoline quinone on defective teeth and mandible in Bmi-1 knockout mice. Zhonghua kou qiang yi xue za zhiChinese Journal of stomatology, 50 (8), 496-502.
26. Kong, L, Yang, C., Yu, L., Smith, W., Zhu, S., Zhu, J., & Zhu, Q. (2013). Pyrroloquinoiine quinine inhibits RANKL-mediated expression of NFATd in part via suppression of c-Fos in mouse bone marrowcells and inhibits wear particle-induced osteolysis in mice. PLoS One, 8(4).26. Kong, L, Yang, C., Yu, L., Smith, W., Zhu, S., Zhu, J., & Zhu, Q. (2013). Pyrroloquinoiine quinine inhibits RANKL-mediated expression of NFATd in part via suppression of c-Fos in mouse bone marrowcells and inhibits wear particle-induced osteolysis in mice. PLoS One, 8 (4).
Qin, R., Sun, J., Wu, J , & Chen, L. (2019). Pyrroloquinoiine quinone prevents knee osteoarthritis by inhibiting oxidative stress and chondrocyte senescence. American Journal of translational research, 11(3), 1460-1472.Qin, R., Sun, J., Wu, J, & Chen, L. (2019). Pyrroloquinoiine quinone prevents knee osteoarthritis by inhibiting oxidative stress and chondrocyte senescence. American Journal of translational research, 11 (3), 1460-1472.
Nakano M, Suzuki H, Imamura T, Lau A, Lynch B Genotoxicity of pymoÎoquinoÎine quinone (PQQ) disodium salt (BioPQQ™). Regul. Toxicol. Pharmacol. 2013;67:189-197.10 1016/j.yrtph.2013.07.007Nakano M, Suzuki H, Imamura T, Lau A, Lynch B Genotoxicity of pymoÎoquinoÎine quinone (PQQ) disodium salt (BioPQQ ™). Regul. Toxic. Pharmacol. 2013; 67: 189-197.10 1016 / j.yrtph.2013.07.007
29. Chun, O. K., & Kim, D. O. (2004). Consideration on equivalent Chemicals in total phenolic assay of chlorogenic acid-rich plums. Food Research International, 37(4), 337-342.29. Chun, O. K., & Kim, D. O. (2004). Consideration on equivalent Chemicals in total phenolic assay of chlorogenic acid-rich plums. Food Research International, 37 (4), 337-342.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ROA202000173A RO134616A0 (en) | 2020-04-01 | 2020-04-01 | Innovative formula with carnosine and pyrroloquinoline quinone for oral administration with the role of neutralizing free radicals in the body - food supplement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ROA202000173A RO134616A0 (en) | 2020-04-01 | 2020-04-01 | Innovative formula with carnosine and pyrroloquinoline quinone for oral administration with the role of neutralizing free radicals in the body - food supplement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RO134616A0 true RO134616A0 (en) | 2020-12-30 |
Family
ID=74067222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ROA202000173A RO134616A0 (en) | 2020-04-01 | 2020-04-01 | Innovative formula with carnosine and pyrroloquinoline quinone for oral administration with the role of neutralizing free radicals in the body - food supplement |
Country Status (1)
| Country | Link |
|---|---|
| RO (1) | RO134616A0 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR20240100037A (en) * | 2024-01-22 | 2025-08-08 | Λεωνιδας Νικολαου Μαμας | FOOD SUPPLEMENT WITH ANTI-AGING ACTION AND FOR THE MANAGEMENT OF MEMORY DECREASE, MILD COGNITIVE IMPAIRMENT, OR THE EARLY STAGE OF ALZHEIMER'S AND PARKINSON'S DISEASE MINDPHOL |
-
2020
- 2020-04-01 RO ROA202000173A patent/RO134616A0/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR20240100037A (en) * | 2024-01-22 | 2025-08-08 | Λεωνιδας Νικολαου Μαμας | FOOD SUPPLEMENT WITH ANTI-AGING ACTION AND FOR THE MANAGEMENT OF MEMORY DECREASE, MILD COGNITIVE IMPAIRMENT, OR THE EARLY STAGE OF ALZHEIMER'S AND PARKINSON'S DISEASE MINDPHOL |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| You et al. | In vitro antioxidant activity and in vivo anti-fatigue effect of loach (Misgurnus anguillicaudatus) peptides prepared by papain digestion | |
| Lamou et al. | Antioxidant and antifatigue properties of the aqueous extract of Moringa oleifera in rats subjected to forced swimming endurance test | |
| JP3122390B2 (en) | Dietary formula preparation | |
| CN107397697B (en) | Whitening and freckle removing composition and application thereof | |
| EP3231437A1 (en) | Aging inhibitor | |
| Muszyńska et al. | Agaricus bisporus and its in vitro culture as a source of indole compounds released into artificial digestive juices | |
| Lei et al. | The antioxidant effect of Asparagus cochinchinensis (Lour.) Merr. shoot in D-galactose induced mice aging model and in vitro | |
| Othman et al. | Nutritional, phytochemical and antioxidant analysis of bee bread from different regions of Malaysia | |
| EP2271367B1 (en) | Mineral absorption accelerator and iron deficiency anemia improver or food composition | |
| US20100004344A1 (en) | Anti-oxidant dietary composition containing fruits and vegetables, method for preparing the same and use of the composition | |
| Peeri et al. | Effect of aqueous extract of saffron and aerobic training on hepatic non enzymatic antioxidant levels in streptozotocin-diabetic rats | |
| JP2024101004A (en) | Heat stress relief | |
| JP2010105937A (en) | Glutathione production promoting composition | |
| RO134616A0 (en) | Innovative formula with carnosine and pyrroloquinoline quinone for oral administration with the role of neutralizing free radicals in the body - food supplement | |
| ES2308550T3 (en) | FORMULATION FOR ORAL ADMINISTRATION EXERCISING A RECONSTITUENT EFFECT ON THE CARDIOVASCULAR SYSTEM. | |
| RU2456825C1 (en) | "eravit" biologically active food additive with antioxidant properties and additive preparation method | |
| US20100297268A1 (en) | Agent for increasing blood adiponectin quantity | |
| RU2283124C1 (en) | Biologically active preparation based on marine vegetable raw | |
| ES2716278T3 (en) | Products for oral administration comprising extracts of pomegranate Punica granatum, designed for a pet, and applications thereof | |
| Adewole et al. | Identification of amino acids and B-vitamins in scotch bonnet pepper (Capsicum chinense) using an HPLC-UV detector | |
| CN112931812B (en) | High-stability oral whitening preparation and preparation method thereof | |
| KR100944717B1 (en) | Whitening cosmetics containing irradiated aquatic boiled water or extract thereof as an active ingredient | |
| JP2010280572A (en) | Glutathione production acceleration composition | |
| KR20200052055A (en) | antioxidant composition comprising Astragalus membranaceus and method of manufacturing the same | |
| Boudebia et al. | Physical-chemical analysis of dried Chamaeleo chamaeleon powder and evaluation of its aqueous extract antioxidation and antiangiogenesis activity |